Quarterly Report • May 14, 2020
Quarterly Report
Open in ViewerOpens in native device viewer

Summary 3 Financial highlights 4 Overview of results and balance sheet 5 Analysis of the quarter 6 Risk statement, economic views and guidance 8
Consolidated financial statements Consolidated income statement 11 Consolidated statement of comprehensive income 13
Consolidated balance sheet 14 Consolidated statement of changes in equity 15 Consolidated cashflow statement 17 Notes on statement of compliance and changes in accounting policies 19 Notes on segment reporting 25 Other notes 26
Credit risk 38 Solvency 44 Income statement, volumes and ratios per business unit 49 Details of ratios and terms 57

The expectations, forecasts and statements regarding future developments that are contained in this report are, of course, based on assumptions and are contingent on a number of factors that will come into play in the future. Consequently, the actual situation may turn out to be (substantially) different.
Investor Relations contact details [email protected] KBC Group NV, Investor Relations Office, Havenlaan 2, 1080 Brussels, Belgium
This report contains information that is subject to transparency regulations for listed companies. Date of release: 14 May 2020
Check this document's authenticity at www.kbc.com/en/authenticity.
'I, Rik Scheerlinck, Chief Financial Officer of the KBC Group, certify on behalf of the Executive Committee of KBC Group NV that, to the best of my knowledge, the abbreviated financial statements included in the quarterly report are based on the relevant accounting standards and fairly present in all material respects the financial condition and results of KBC Group NV including its consolidated subsidiaries, and that the quarterly report provides a fair view of the main events, the main transactions with related parties in the period under review and their impact on the abbreviated financial statements, and an overview of the main risks and uncertainties for the remainder of Forward- the current year.' looking statements

| KBC Group – overview (consolidated, IFRS) | 1Q2020 | 4Q2019 | 1Q2019 |
|---|---|---|---|
| Net result (in millions of EUR) | -5 | 702 | 430 |
| Basic earnings per share (in EUR) | -0.04 | 1.66 | 0.98 |
| Breakdown of the net result by business unit (in millions of EUR) | |||
| Belgium | -86 | 412 | 176 |
| Czech Republic | 88 | 205 | 177 |
| International Markets | 35 | 119 | 70 |
| Group Centre | -43 | -33 | 7 |
| Parent shareholders' equity per share (in EUR, end of period) | 43.8 | 45.3 | 43.1 |
In the quarter under review, we were confronted with the outbreak and spread of the coronavirus, the long-term impact of which on the economy remains quite uncertain at this moment in time. As an employer and service provider, we reacted quickly to try to safeguard the health of our staff and clients, while ensuring that services continue to be provided. As many staff as possible are working from home and we are providing our clients with advice through a wide range of phone and digital channels. We have been working hard with government agencies of our core countries to support all customers impacted by coronavirus by processing loan deferral requests promptly, and efficiently instituting other relief measures. We are clearly benefiting from the efforts and investments we have made over the past few years on the digital transformation front. These efforts and investments, along with the expertise and motivation of our employees in all our home countries and the strength of our multichannel distribution network, allow us to provide our customers with a level of service that is very close to precoronavirus crisis levels.
As regards our financial results, we incurred a net loss of 5 million euros in the first quarter of 2020, caused mainly by the impact of the worldwide coronavirus outbreak on our trading and fair value result and the upfront booking of bank taxes.
In the quarter under review, our trading and fair value result came to a negative 0.4 billion euros, as a result of a number of market-driven factors, such as sharply lower stock markets, widening credit spreads and lower long-term interest rates.
The impact of the coronavirus crisis on the other profit and loss lines in the quarter under review was less pronounced. Compared to the year-earlier quarter, our core income lines, i.e. net interest income, net fee & commission income and the technical insurance result, performed quite well. Costs were kept well under control, too. They decreased slightly year-on-year after excluding the impact of the consolidation of ČMSS, bank taxes (the bulk of the full-year amount of these taxes is usually recorded in the first quarter) and some one-off items. Loan loss provisions increased in the quarter under review and included an additional 43 million euros specifically related to the coronavirus crisis, based on our exposure to sectors we believe will be affected most by the crisis. For full-year 2020, we estimate impairments to amount to roughly 1.1 billion euros (base scenario).
Generally speaking, volumes held up well year-on-year: on a comparable scope basis, loans and advances increased by 6%, deposits by 5% and earned non-life insurance premiums by 7%. On the other hand, sales of life insurance products fell by 17% year-on-year.
Our solvency position remained very strong, with a common equity ratio of 16.3% on a fully loaded basis, well above the current minimum capital requirement of 8.05%. This minimum requirement takes into account the various announced ECB and National Banks' measures which have provided significant temporary relief on the minimum capital requirements. Our liquidity position remained solid too, with an LCR of 135% and an NSFR of 134% at the end of March 2020. We are especially pleased that the hard work in recent years has paid off in making our group strong and healthy. As a result, our current capital and liquidity buffers allow us to face today's challenges with confidence.

Ultimately, our goal remains the same: to ensure that our customers are at the centre of everything we do, something which our employees are committed to in their day-to-day work. I wish to express my utmost appreciation to all colleagues who have expended huge efforts to serve our customers and support the sound functioning of the group from home offices and other remote locations. In closing, I would also like to take this opportunity to explicitly thank all those stakeholders who have – in these challenging times continued to put their trust in us.
Johan Thijs, Chief Executive Officer


Our strategy rests on four principles:
• We place our customers at the centre of everything we do
• We look to offer our customers a unique bank-insurance experience
• We focus on our group's long-term development and aim to achieve
sustainable and profitable growth
• We meet our responsibility to society and local economies




| Consolidated income statement, IFRS KBC Group (in millions of EUR) |
1Q2020 | 4Q2019 | 3Q2019 | 2Q2019 | 1Q2019 |
|---|---|---|---|---|---|
| Net interest income | 1 195 | 1 182 | 1 174 | 1 132 | 1 129 |
| Non-life insurance (before reinsurance) | 185 | 229 | 192 | 174 | 161 |
| Earned premiums | 443 | 441 | 440 | 425 | 415 |
| Technical charges | -258 | -212 | -248 | -251 | -254 |
| Life insurance (before reinsurance) | 0 | 2 | -5 | 1 | -3 |
| Earned premiums | 297 | 364 | 291 | 317 | 351 |
| Technical charges | -297 | -363 | -297 | -316 | -354 |
| Ceded reinsurance result | -7 | -11 | -9 | 1 | -7 |
| Dividend income | 12 | 17 | 14 | 39 | 12 |
| Net result from financial instruments at fair value through P&L1 | -385 | 130 | -46 | -2 | 99 |
| Net realised result from debt instruments at fair value through other comprehensive income |
0 | 0 | 5 | 0 | 2 |
| Net fee and commission income | 429 | 445 | 444 | 435 | 410 |
| Net other income | 50 | 47 | 43 | 133 | 59 |
| Total income | 1 479 | 2 041 | 1 813 | 1 913 | 1 862 |
| Operating expenses | -1 338 | -1 045 | -975 | -988 | -1 296 |
| Impairment | -141 | -82 | -26 | -40 | -69 |
| Of which: on financial assets at amortised cost and at fair value through other comprehensive income2 |
-121 | -75 | -25 | -36 | -67 |
| Share in results of associated companies & joint ventures | -3 | -1 | 0 | 4 | 5 |
| Result before tax | -3 | 912 | 812 | 889 | 503 |
| Income tax expense | -2 | -210 | -200 | -144 | -73 |
| Result after tax | -5 | 702 | 612 | 745 | 430 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | -5 | 702 | 612 | 745 | 430 |
| Basic earnings per share (EUR) | -0.04 | 1.66 | 1.44 | 1.76 | 0.98 |
| Diluted earnings per share (EUR) Key consolidated balance sheet figures |
-0.04 | 1.66 | 1.44 | 1.76 | 0.98 |
| KBC Group (in millions of EUR) | 31-03-2020 | 31-12-2019 | 30-09-2019 | 30-06-2019 | 31-03-2019 |
| Total assets | 301 451 | 290 735 | 294 830 | 289 548 | 292 332 |
| Loans and advances to customers, excl. reverse repos | 158 364 | 155 816 | 154 863 | 154 169 | 148 517 |
| Securities (equity and debt instruments) | 67 176 | 65 633 | 65 122 | 63 746 | 63 706 |
| Deposits from customers & debt certificates, excl. repos | 208 293 | 203 369 | 205 270 | 199 138 | 197 987 |
| Technical provisions, before reinsurance | 18 816 | 18 560 | 18 549 | 18 652 | 18 589 |
| Liabilities under investment contracts, insurance | 11 979 | 13 610 | 13 456 | 13 381 | 13 334 |
| Parent shareholders' equity | 18 220 | 18 865 | 18 086 | 17 799 | 17 924 |
| Selected ratios KBC group (consolidated) |
1Q2020 | FY2019 | |||
| Return on equity | -0.4%3 | 14% | |||
| Cost/income ratio, banking | 91% | 58% | |||
| (when excluding certain non-operating items and spreading bank taxes evenly throughout the year) | (69%) | (58%) | |||
| Combined ratio, non-life insurance | 90% | 90% | |||
| Common equity ratio, Basel III Danish Compromise (fully loaded) | 16.3% | 17.1% | |||
| Common equity ratio, FICOD (fully loaded) | 15.3% | 15.8% | |||
| Leverage ratio, Basel III (fully loaded) | 6.5% | 6.8% | |||
| Credit cost ratio | 0.27% | 0.12% | |||
| Impaired loans ratio | 3.3% | 3.5% | |||
| for loans more than 90 days past due | |||||
| 1.9% | 1.9% | ||||
| Net stable funding ratio (NSFR) Liquidity coverage ratio (LCR) |
134% 135% |
136% 138% |
1 Also referred to as 'Trading and fair value income'.
2 Also referred to as 'Loan loss impairment'.
3 4% when bank taxes are spread evenly throughout the year.
We provide a full overview of our IFRS consolidated income statement and balance sheet in the 'Consolidated financial statements' section of the quarterly report. Condensed statements of comprehensive income, changes in shareholders' equity, as well as several notes to the accounts, are also available in the same section. As regards the (changes in) definition of ratios, see 'Details of ratios and terms' in the quarterly report.
1 479 million euros
Total income Total income decreased by 28% quarter-on-quarter, due almost entirely to a very steep decline in trading and fair value income caused by the coronavirus-induced financial market turmoil. All other income items combined fell slightly quarter-on-quarter, with the decrease in technical insurance income and in net fee and commission income being partly offset by higher net interest income.
The drop in total income in the quarter under review was mostly accounted for by a significant decline in the net result from financial instruments at fair value (trading and fair value income), which went from a positive 130 million euros and 99 million euros in the previous and year-earlier quarters, respectively, to a negative 385 million euros in the first quarter of 2020, due essentially to the impact of the coronavirus (Covid-19) crisis. As this crisis impacted markets worldwide (anticipating a severe recession in 2020), it caused stock markets to tumble, credit spreads to widen and long-term interest rates to fall, among other effects. Consequently, impairments on shares at the insurance company increased notably, significant negative (mainly counterparty and funding) value adjustments were recorded, the value of derivatives used for asset/liability management purposes became negative and our dealing room result fell. The combined effect of these factors led to the negative 385 million euros in this income line.
In the quarter under review, the impact of the coronavirus crisis on other income items (see below) was less pronounced.
Net interest income amounted to 1 195 million euros in the quarter under review, up 1% on the figure recorded in the previous quarter and by as much as 6% year-on-year. Net interest income continued to benefit from the positive effect of loan volume growth, lower funding costs (quarter-on-quarter), the positive impact of ECB tiering, the full consolidation of ČMSS since June 2019 (therefore, not included in the first quarter of 2019 – referred to as the 'ČMSS impact'), the higher netted positive impact of ALM FX swaps, the effect of earlier rate hikes in the Czech Republic, as well as a few one-off items. These items were partly offset by a number of factors, including pressure on loan portfolio margins (despite a recovery of the margin on a large part of the new loan production in Belgium), the lower number of days in the period under review (quarter-on-quarter) and the negative effect of lower reinvestment yields in our core countries in the euro area.
The total volume of customer lending (158 billion euros) increased by 3% quarter-on-quarter and by as much as 8% year-on-year (excluding the forex impact). On a comparable scope basis, i.e. excluding the ČMSS impact and some smaller changes in the scope of consolidation, the year-on-year increase amounted to 6%, with growth recorded in all business units. Customer deposits including debt certificates (208 billion euros) were up 4% quarter-on-quarter and 7% year-on-year (excluding the forex impact). On a comparable basis, the year-on-year increase was 5%, again with growth in all business units. The net interest margin amounted to 1.97% for the quarter under review, 3 basis points up on the figures recorded in the previous quarter and 1 basis point down on the level recorded in the year-earlier quarter.
Technical income from our non-life insurance activities (earned premiums less technical charges, plus the ceded reinsurance result) contributed 173 million euros to total income, down 21% quarter-on-quarter, but up 12% on the corresponding year-earlier quarter. The quarter-on-quarter decrease was caused primarily by the storm impact in Belgium in the quarter under review. The year-on-year increase was due mainly to higher earned premiums (+7%), while technical charges rose only slightly (by 2%; note that the first quarter of 2019 had been impacted by storms too). Overall, the combined ratio for the first quarter of 2020 came to an excellent 90%, in line with the figure recorded for full-year 2019 and an improvement on the 93% recorded in the first quarter of 2019.
Technical income from our life insurance activities amounted to 4 million euros, compared to 1 million euros in the previous quarter and -3 million euros in the year-earlier quarter. Sales of life insurance products in the quarter under review (427 million euros) were down 9% on the level recorded in the previous quarter (which had benefited from traditionally high volumes of taxincentivised pension savings products in the last quarter of the year). They were down 17% on the year-earlier quarter, due to lower sales of guaranteed-interest products (due to the suspension of the sale of universal single life insurance products in Belgium) and lower sales of unit-linked products in Belgium and the Czech Republic. Overall, the share of guaranteed-interest products in our total life insurance sales amounted to 58% in the quarter under review, with unit-linked products accounting for the remaining 42%.
In the quarter under review, net fee and commission income amounted to 429 million euros. Compared to the previous quarter, this represented a drop of 4% caused by a combination of lower fees from our asset management services (due in part to the decrease in assets under management – see below) and lower fees from our banking services (the decrease in payment-services fees and loan-related fees not fully compensated by the increase in fees from securities transactions), partly offset by the lower level of paid distribution fees. Compared to the first quarter of 2019, net fee and commission income rose by 5%, thanks to both higher asset management-related fees and banking-services-related fees, with the latter being helped by the ČMSS impact. At the end of March 2020, our total assets under management amounted to 193 billion euros, down 11% quarter-on-quarter and 8% year-on-year. In both cases, this was accounted for primarily by the negative impact of falling asset prices triggered by the financial market turmoil in March following the outbreak of the coronavirus pandemic (-10% quarter-on-quarter and -5% year-on-year) and – to a lesser extent – by net outflows (-1% quarter-on-quarter and -3% year-on-year). It should be noted that the mutual fund business witnessed net inflows in the quarter under review (+0.6 billion euros), but these were offset by net outflows in investment advice and group assets.
The other remaining income items included dividend income of 12 million euros, as well as 50 million euros in net other income (in line with the normal run rate for this item).
Operating expenses Excluding bank taxes, operating expenses in the first quarter were down 6% compared to the previous quarter. The cost/income ratio amounted to 91%, or 69% excluding 1 338 million euros certain non-operating items and when bank taxes are spread evenly through the year.
Operating expenses in the first quarter of 2020 amounted to 1 338 million euros and, as usual, included the bulk of the bank taxes for the full year (407 million euros in the quarter under review, compared to 51 million euros in the previous quarter and 382 million euros in the year-earlier quarter). Excluding these taxes, expenses decreased by 6% quarter-on-quarter, thanks in part to seasonally lower marketing costs & professional fees and lower staff expenses. Year-on-year, expenses excluding bank taxes increased by 2%, due mainly to the ČMSS impact and a number of other factors such as wage drift (partly offset by a decrease in FTEs), higher depreciation, as well as a number of one-off items. Excluding the ČMSS impact and some one-off items, expenses excluding bank taxes were slightly down year-on-year.
The cost/income ratio of our banking activities came to 91%, but was distorted by most of the bank taxes being recorded in the first quarter. Excluding certain non-operating items and spreading bank taxes evenly throughout the year, the ratio was 69%, compared to 58% for full year 2019. The worsening of the ratio is clearly related to the fall in total income due to the hit taken by trading and fair value income.
| Loan loss impairment 121-million-euro charge |
We recorded a net loan loss impairment charge of 121 million euros, up on the 75 million euros recorded in the previous quarter. The annualised credit cost ratio amounted to 0.27% for the first quarter of the year. The current quarter included 43 million euros related to the impact of the coronavirus pandemic in the quarter under review (as a management overlay, in accordance with IFRS 9). |
|---|---|
In the first quarter of 2020, we recorded a 121-million-euro net loan loss impairment charge, compared with a net charge of 75 million euros in the previous quarter and 67 million euros in the first quarter of 2019. A large part of the loan loss provisions for the quarter under review was related to a number of corporate loans in Belgium, as was the case in previous quarters. The quarter's figure also included 43 million euros specifically related to the coronavirus crisis (based on our exposure to a number of economic sectors which we believe will be affected most by the crisis; a detailed calculation and background information can be found in Note 1.4 of the 'Consolidated financial statements' section of the quarterly report).
Broken down by country, loan loss impairment charges in the first quarter of 2020 came to 116 million euros in Belgium, 8 million euros in the Czech Republic, 6 million euros in Slovakia and 3 million euros in Bulgaria, while there were net impairment releases of 2 million euros in Hungary, 1 million euros in Ireland and 9 million euros in the Group Centre. For the entire group, the annualised credit cost ratio increased to 0.27% for the quarter under review (0.17% excluding the amount recorded for the coronavirus pandemic), up from 0.12% for full year 2019.
The impaired loans ratio has improved slightly since the start of the year. At the end of March 2020, some 3.3% of our total loan book was classified as impaired, compared to 3.5% at year-end 2019. Impaired loans that are more than 90 days past due amounted to 1.9% of the loan book, comparable to the figure recorded at year-end 2019.
Impairment on assets other than loans amounted to 20 million euros, compared to 7 million euros in the previous quarter and 1 million euros in the first quarter of 2019. The figure for the quarter under review includes an 18-million-euro one-off item related to the payment moratorium in Hungary.
For an indication of the expected full-year 2020 impairment impact, see 'Guidance' on page 9 of this publication.
| Net result | Belgium | Czech Republic | International Markets | Group Centre |
|---|---|---|---|---|
| by business unit | -86 | 88 | 35 | -43 |
| million euros | million euros | million euros | million euros |
Belgium: the net result (-86 million euros) fell by 497 million euros quarter-on-quarter. Excluding bank taxes (the bulk of which are recorded in the first quarter and hence distort the quarter-on-quarter comparison), the net result fell by 282 million euros (-68%), due almost entirely to the significant drop in trading and fair value income caused by the coronavirus-induced economic turmoil. That aside, net interest income and net fee and commission income rose slightly quarter-on-quarter, while the technical non-life insurance result (storm impact), dividend income and net other income all fell. Costs excluding bank taxes were down somewhat on the previous quarter and loan loss impairment charges were slightly higher quarter-on-quarter (including an amount recorded in relation to the coronavirus crisis).
Czech Republic: the net result (88 million euros) was down 57% on its level for the previous quarter, or 41% excluding bank taxes. As in Belgium, this is almost entirely due to the significant drop in trading and fair value income in the quarter under review. That aside, total income benefited from increased net interest income, technical insurance income and net other income, which more than offset the decrease in net fee and commission income. Costs excluding bank taxes fell and loan loss impairment charges went up (including an amount recorded in relation to the coronavirus crisis).
International Markets: the 35-million-euro net result breaks down as follows: 4 million euros in Slovakia, 10 million euros in Hungary, 10 million euros in Bulgaria and 12 million euros in Ireland. For the business unit as a whole, the net result was down 71% quarter-on-quarter, or 38% excluding bank taxes. The latter decrease came about mainly on account of a combination of the drop in trading and fair value income, lower net fee and commission income (mainly in Hungary and partly seasonal) and higher impairment charges in all countries (including a one-off item in Hungary, as well as an amount recorded in Hungary and Slovakia in relation to the coronavirus crisis).
Group Centre: the net result (-43 million euros) was down 10 million euros quarter-on-quarter, caused in part by lower trading and fair value income and – to a lesser extent – lower net interest income, which more than offset the decrease in costs in the quarter under review.
| Belgium | Czech Republic | International Markets | ||||
|---|---|---|---|---|---|---|
| Selected ratios by business unit | 1Q2020 | FY2019 | 1Q2020 | FY2019 | 1Q2020 | FY2019 |
| Cost/income ratio, banking (excluding certain non-operating items and spreading bank taxes evenly throughout the year) |
67% | 60% | 59% | 47% | 74% | 68% |
| Combined ratio, non-life insurance | 95% | 89% | 90% | 94% | 82% | 88% |
| Credit cost ratio* | 0.40% | 0.22% | 0.10% | 0.04% | 0.08% | -0.07% |
| Impaired loans ratio | 2.2% | 2.4% | 2.2% | 2.3% | 8.2% | 8.5% |
* A negative figure indicates a net impairment release (positively affecting results). See 'Details of ratios and terms' in the quarterly report.
A full results table is provided in the 'Additional information' section of the quarterly report. A short analysis of the results per business unit is provided in the analyst presentation (available at www.kbc.com).
| Equity, solvency and liquidity |
Total equity |
Common equity ratio (fully loaded) |
Liquidity coverage ratio |
Net stable funding ratio |
|---|---|---|---|---|
| 19.7 billion euros | 16.3% | 135% | 134% |
At the end of March 2020, total equity amounted to 19.7 billion euros, comprising 18.2 billion euros in parent shareholders' equity and 1.5 billion euros in additional tier-1 instruments. Total equity was down 0.6 billion euros on its level at the end of 2019, owing to the combined effect of a number of items, including the decrease in the revaluation reserves for FVOCI debt instruments (-0.2 billion euros, due to higher credit spreads) and for equity instruments of the insurance company (the so-called 'insurance overlay approach'; -0.2 billion euros, related to falling stock markets), net translation differences (-0.3 billion euros, due largely to the depreciation of the Czech koruna and Hungarian forint in the quarter under review) and a number of other minor items. We have provided details of these changes in the 'Consolidated financial statements' section of the quarterly report (under 'Consolidated statement of changes in equity').
Please note that (as mentioned earlier), in line with ECB recommendations, our Board of Directors withdrew the proposal to the Annual General Meeting of 7 May 2020 to pay a final total (gross) dividend of 2.5 euros per share for 2019 (after an interim dividend of 1 euro per share had been paid in November 2019). Therefore, no final dividend will be paid in May. The Board also decided to evaluate in October 2020 whether all or part of this withdrawn final dividend should be paid out later this year in the form of an interim dividend, and to cancel the proposed share buy-back programme of 5.5 million shares.
At 31 March 2020, our fully loaded common equity ratio (Basel III, under the Danish compromise) amounted to 16.3%, compared to 17.1% at the end of 2019. The 0.8 percentage point decrease was mainly coronavirus-related (0.5 percentage points, mainly due to FX and a volume growth related risk-weighted assets increase). Our leverage ratio (Basel III, fully loaded) came to 6.5%, compared to 6.8% at the end of 2019. The solvency ratio for KBC Insurance under the Solvency II framework was a sound 212% at the end of March 2020, compared to 202% at the end of 2019. Our liquidity position remained excellent too, as reflected in an LCR ratio of 135% and an NSFR ratio of 134% at the end of the quarter under review (compared to 138% and 136%, respectively, at the end of 2019).
As we are mainly active in banking, insurance and asset management, we are exposed to a number of typical risks for these financial sectors such as – but not limited to – credit default risk, counterparty credit risk, concentration risk, movements in interest rates, currency risk, market risk, liquidity and funding risk, insurance underwriting risk, changes in regulations, operational risk, customer litigation, competition from other and new players, as well as the economy in general. KBC closely monitors and manages each of these risks within a strict risk framework, but they may all have a negative impact on asset values or could generate additional charges beyond anticipated levels.
At present, a number of items are considered to constitute the main challenges for the financial sector. These stem primarily from the impact of the coronavirus crisis on the global economy and, in particular, the financial sector (including credit, market and liquidity risks and the impact of persisting low interest rates on our results). These risks come on top of risks relating to macroeconomic and political developments, such as Brexit and trade conflicts, all of which affect global and European economies, including KBC's home markets. Regulatory and compliance risks (including anti-money laundering regulations and GDPR) remain a dominant theme for the sector, as does enhanced consumer protection. Digitalisation (with technology as a catalyst) presents both opportunities and threats to the business model of traditional financial institutions, while climate-related risks are becoming increasingly prevalent. Finally, cyber risk has become one of the main threats during the past few years, not just for the financial sector, but for the economy as a whole.
We provide risk management data in our annual reports, quarterly reports and dedicated risk reports, all of which are available at www.kbc.com.
The coronavirus crisis is a major shock to the global economy. In this context, fiscal and monetary policy initiatives aim to mitigate the economic impact of the pandemic and to boost recovery. Wherever possible, interest rates were quickly lowered and massive amounts of liquidity injected into the financial markets, where the demand for cash surged due to uncertainty. Moreover, additional unconventional policy tools have been used by central banks seeking to ensure that additional debt can be created at reasonable interest rates. Monetary policy is expected to stay extremely accommodative in the future.
Long-term bond yields are expected to remain low in the US and the euro area throughout 2020 due to exceptionally expansionary monetary policy and safe-haven effects. Some normalisation will gradually occur, but that will depend on further developments in various areas, such as the coronavirus crisis, Brexit, the US-China trade war and the US presidential elections. Intra-EMU sovereign spreads are likely to remain low as the ECB is expected to be able to limit interest-rate differentials.
After raising its policy rate earlier this year, the Czech National Bank (CNB) again lowered its two-week repo rate in several steps from 2.25% to 0.25% in response to the coronavirus crisis. Some continued weakness in the CZK can be expected due to these changes in monetary policy and the general market turmoil surrounding emerging market currencies. The CNB has been legally enabled to rely on quantitative easing tools in case the economic situation necessitates such market interventions. Finally, the CNB is continuing to take a flexible approach to how financial institutions are to comply with their regulatory duties in order to reduce the regulatory burden and to create room for more flexible reactions to the challenging economic environment.
Economic growth in 2020 will move into negative territory in the euro area and the US as a consequence of demand- and supplyside disruptions triggered by the coronavirus crisis. However, we envisage a strong recovery in 2021, due to the fact that, rather than being a normal recession, the current economic situation is a temporary standstill brought about by virus containment measures. Once these measures are gradually lifted, economic activity is expected to gradually pick up again. Moreover, the recovery will be boosted by various policy initiatives to mitigate the economic damage. However, this scenario is subject to considerable uncertainty as risks remain tilted to the downside.
| Guidance | • The full-year 2020 Net Interest Income guidance has been lowered from 4.65 billion euros to approximately 4.3 billion euros, mainly due to the CNB rate cuts (roughly -0.2 billion euros) and the depreciation of the CZK and HUF versus the EUR (roughly -0.1 billion euros); |
|---|---|
| • The full-year 2020 guidance for Operating Expenses Excluding Bank Taxes has been changed from maximum +1.6% year-on-year towards approximately -3.5% year-on-year due to extra cost savings; |
|
| • As a result of the coronavirus pandemic, we estimate the full-year 2020 Impairments at roughly 1.1 billion euros (base scenario). Depending on a number of events such as the length and depth of the economic downturn, the significant number of government measures in each of our core countries, some of which still need to be worked out in detail, and the unknown amount of customers who will call upon these mitigating actions, we estimate the full-year 2020 impairment to range between roughly 0.8 billion euros (optimistic scenario) and roughly 1.6 billion euros (pessimistic scenario); |
|
| • The impact of the coronavirus-lockdown on digital sales, services and digital signing so far has been very positive. KBC is clearly benefitting from the digital transformation efforts made so far; |
|
| • Basel 4 has been postponed by 1 year (as of 1 January 2023 instead of 2022). |
| Upcoming events | 2Q2020 results: 6 August 2020 3Q2020 results: 12 November 2020 |
|---|---|
| More information on 1Q2020 |
Quarterly report: www.kbc.com / Investor Relations / Reports Company presentation: www.kbc.com / Investor Relations / Presentations |
| Definitions of ratios | 'Details of ratios and terms at KBC Group level' in the last section of the quarterly report. |
__
Consolidated financial statements according to IFRS

Section reviewed by the Auditor
AC: Amortised Cost AFS: Available For Sale (IAS 39) ALM: Asset Liability Management ECL: Expected Credit Loss FA: Financial Assets FV: Fair Value FVA: Funding Value Adjustment FVO: Fair Value Option (designated upon initial recognition at Fair Value through Profit or Loss) FVOCI: Fair Value through Other Comprehensive Income FVPL: Fair Value through Profit or Loss FVPL – overlay: Fair Value through Profit or Loss - overlay GCA: Gross Carrying Amount HFT: Held For Trading MFVPL: Mandatorily Measured at Fair Value through Profit or Loss (including HFT) OCI: Other Comprehensive Income POCI: Purchased or Originated Credit Impaired Assets SPPI: Solely payments of principal and interest SRB: Single Resolution Board
R/E: Retained Earnings
| (in millions of EUR) | Note | 1Q 2020 | 4Q 2019 | 1Q 2019 |
|---|---|---|---|---|
| Net interest income | 3.1 | 1 195 | 1 182 | 1 129 |
| Interest income | 3.1 | 1 936 | 1 809 | 1 821 |
| Interest expense | 3.1 | - 741 | 627 ı |
692 - |
| Non-life insurance (before reinsurance) | 3.7 | 185 | 229 | 161 |
| Earned premiums | 3.7 | 443 | 441 | 415 |
| Technical charges | 3.7 | 258 | 212 | 254 |
| Life insurance (before reinsurance) | 3.7 | 0 | 2 | - 3 |
| Earned premiums | 3.7 | 297 | 364 | 351 |
| Technical charges | 3.7 | - 297 | - 363 | 354 - |
| Ceded reinsurance result | 3.7 | - 7 | 11 | - 7 |
| Dividend income | 12 | 17 | 12 | |
| Net result from financial instruments at fair value through profit or loss | 3.3 | - 385 | 130 | පිහි |
| of which result on equity instruments (overlay approach) | 82 | 28 | 29 | |
| Net realised result from debt instruments at fair value through OCI | 0 | 0 | 2 | |
| Net fee and commission income | 3.5 | 429 | 445 | 410 |
| Fee and commission income | 3.5 | 628 | 643 | 588 |
| Fee and commission expense | 3.5 | - 199 | - 198 | 178 - |
| Net other income | 3.6 | 50 | 47 | ਦਰ |
| TOTAL INCOME | 1 479 | 2 041 | 1 862 | |
| Operating expenses | 3.8 | - 1 338 | - 1 045 | - 1 296 |
| Staff expenses | 3.8 | - 594 | 602 । |
567 - |
| General administrative expenses | 3.8 | - 654 | 352 | 647 l |
| Depreciation and amortisation of fixed assets | 3.8 | - 89 | - 92 | 82 - |
| Impairment | 3.10 | - 141 | 82 | દિવે - |
| on financial assets at AC and at FVOCI | 3.10 | - 121 | 75 | 67 - |
| on goodwill | 3.10 | 0 | 0 | 0 |
| other | 3.10 | - 20 | 7 | 1 |
| Share in results of associated companies and joint ventures | 3 | 1 । |
5 | |
| RESULT BEFORE TAX | 3 | 912 | 503 | |
| Income tax expense | 3.12 | 2 | - 210 | 73 - |
| Net post-tax result from discontinued operations | 0 | O | 0 | |
| RESULT AFTER TAX | - 5 | 702 | 430 | |
| attributable to minority interests | 0 | 0 | O | |
| of which relating to discontinued operations | 0 | 0 | 0 | |
| attributable to equity holders of the parent | - 5 | 702 | 430 | |
| of which relating to discontinued operations | 0 | 0 | 0 | |
| Earnings per share (in EUR) | ||||
| Ordinary | -0.04 | 1.66 | 0.98 | |
| Diluted | -0.04 | 1.66 | 0.98 |
The equity instruments of the insurance companies within the group are designated under the overlay approach. These equity instruments, mainly classified as AFS under IAS 39, would have been measured at fair value through P&L under IFRS 9. The overlay approach reclassifies from the income statement to OCI the extra volatility related to the adoption of IFRS 9 as long as IFRS 17 is not in place, until 31 December 2022 (subject to EU endorsement).
The extra volatility due to IFRS 9, reclassified out of the net result from financial instruments at fair value through profit or loss to the revaluation reserves of equity instruments (overlay approach) refers to the unrealised fair value fluctuations amounting to -225 million euros in 1Q 2020. It can be summarized as the difference between :
| (in millions of EUR) | 1Q 2020 4Q 2019 1Q 2019 | ||
|---|---|---|---|
| RESULT AFTER TAX | 5 - |
702 | 430 |
| attributable to minority interests | 0 | O | O |
| attributable to equity holders of the parent | 5 | 702 | 430 |
| OCI THAT MAY BE RECYCLED TO PROFIT OR LOSS | - 745 | - 49 | 244 |
| Net change in revaluation reserve (FVOCI debt instruments) | - 182 | - 247 | 194 |
| Net change in revaluation reserve (FVPL equity instruments) - overlay | - 225 | 41 | 121 |
| Net change in hedging reserve (cashflow hedges) | - 24 | 105 | - 65 |
| Net change in translation differences | - 395 | 68 | 8 |
| Hedge of net investments in foreign operations | 80 | - 5 | N |
| Net change in respect of associated companies and joint ventures | O | - 12 | 2 |
| Other movements | 2 | 1 | 1 |
| OCI THAT WILL NOT BE RECYCLED TO PROFIT OR LOSS | 113 | 124 | 33 |
| Net change in revaluation reserve (FVCI equity instruments) | - 4 | - 8 | 7 |
| Net change in defined benefit plans | 100 | 131 | 29 |
| Net change in own credit risk | 17 | O | - 2 |
| Net change in respect of associated companies and joint ventures | O | O | 1 |
| TOTAL COMPREHENSIVE INCOME | - 637 | 777 | 708 |
| attributable to minority interests | O | O | O |
| attributable to equity holders of the parent | - 637 | 778 | 708 |
The largest movements in other comprehensive income (1Q 2020 vs. 1Q 2019):
| (in millions of EUR) | Note 31-03-2020 31-12-2019 | |
|---|---|---|
| ASSETS | ||
| Cash, cash balances with central banks and other demand deposits with credit institutions | 7 489 | 8 356 |
| Financial assets 4.0 |
283 586 | 273 399 |
| Amortised cost 4.0 |
238 890 | 230 639 |
| 4.0 Fair value through OCI |
18 427 | 19 037 |
| 4.0 Fair value through profit or loss |
26 091 | 23 563 |
| of which held for trading 4.0 |
11 574 | 7 266 |
| 4.0 Hedging derivatives |
178 | 158 |
| Reinsurers' share in technical provisions, insurance | 134 | 121 |
| Fair value adjustments of the hedged items in portfolio hedge of interest rate risk | 1 333 | 478 |
| Tax assets | 1 565 | 1 396 |
| Current tax assets | 103 | ઉદ |
| Deferred tax assets | 1 462 | 1 300 |
| Non-current assets held for sale and disposal groups | 45 | 29 |
| Investments in associated companies and joint ventures | 23 | 25 |
| Property, equipment and investment property | 3 710 | 3 818 |
| Goodwill and other intangible assets | 1 594 | 1 640 |
| Other assets | 1 973 | 1 474 |
| TOTAL ASSETS | 301 451 | 290 735 |
| LIABILITIES AND EQUITY | ||
| Financial liabilities 4.0 |
258 723 | 248 400 |
| Amortised cost 4.0 |
235 448 | 224 093 |
| Fair value through profit or loss 4.0 |
21 910 | 23 137 |
| 4.0 of which held for trading |
7 667 | 6 988 |
| 4.0 Hedging derivatives |
1 364 | 1 171 |
| Technical provisions, before reinsurance | 18 816 | 18 560 |
| Fair value adjustments of the hedged items in portfolio hedge of interest rate risk | 244 | - 122 |
| Tax liabilities | 499 | 478 |
| Current tax liabilities | 166 | ರಿಕ |
| Deferred tax liabilies | 333 | 380 |
| Provisions for risks and charges | 264 | 227 |
| Other liabilities | 3 184 | 2 827 |
| TOTAL LIABILITIES | 281 731 | 270 371 |
| 5.10 I otal equity |
19 720 | 20 365 |
| Parent shareholders' equity 5.10 |
18 220 | 18 865 |
| 5.10 Additional tier-1 instruments included in equity |
1 500 | 1 500 |
| Minority interests | O | O |
| TOTAL LIABILITIES AND EQUITY | 301 451 | 290 735 |
| Revalu- | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revalu- | ation | Revalu- | |||||||||||||||
| ation | reserve | ation | Hedge of Remeas- | ||||||||||||||
| lssued and |
reserve (FVOCI |
(FVPL equity |
reserve (FVOCI |
Hedging reserve |
Trans- | invest- | net urement of |
Own credit |
Parent | Additional tier-1 |
|||||||
| paid up | debt | instru- | equity | (cash- | lation | ments in | defined | risk | Total | share- instruments | |||||||
| share | Share Treasury Retained | ınstru- | ments) - | instru- | flow | diffe- | foreign | benefit | through | revaluation | holders' included in | Minority | Total | ||||
| (in millions of EUR) | capital premium | shares earnings | ments) | overlay | ments) | hedges) | rences opera-tions | plans | OCI | reserves | equity | equity interests | equity | ||||
| 31-03-2020 | |||||||||||||||||
| Balance at the end of the previous period | 1 458 | 5 498 | 2 | 11 875 | 992 | 350 | 32 | - 1 331 | 92 - |
89 | 0 | 4 | 37 | 18 865 | 1 500 | 0 | 20 365 |
| Net result for the period | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | O | 0 | 0 | . 5 | 0 | 0 | 5 |
| Other comprehensive income for the period | 0 | 0 | 0 | 2 | 182 - |
225 - |
4 | 24 - |
395 | 80 | 100 | 17 | 633 | 631 | 0 | 0 | 631 |
| Subtotal | 0 | 0 | 0 | 4 | 182 - |
225 | 4 - |
24 - |
395 - |
80 | 100 | 17 | 633 | 637 | 0 | 0 | 637 |
| Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coupon on AT1 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 9 |
| Transfer from revaluation reserves to retained earnings on realisation | 0 | 0 | 0 | 0 | 0 | 1 - |
0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | |
| Purchase/sale of treasury shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | |
| Total change | 0 | 0 | 12 | 182 - |
225 - |
5 | 24 - |
395 | 80 | 100 | 17 | 634 | 644 | 0 | 0 | 644 | |
| Balance at the end of the period | 1 458 | 5 498 | 1 | 11 863 | 809 | 125 | 28 | 1 355 - |
486 ' |
169 | 101 | 13 | 597 | 18 220 | 1 500 | 0 | 19 720 |
| of which relating to the equity method | 0 | 0 | 2 | 0 | 0 | O | 0 | 0 | 2 | 2 | 2 | ||||||
| 2019 | |||||||||||||||||
| Balance at the end of the previous period | 1 457 | 5 482 | રે | 10 901 | રકેશ | 159 | 22 | - 1 263 | 73 ' |
8୧ | 119 - |
ਤ - |
605 | 17 233 | 2 400 | 0 | 19 633 |
| Net result for the period | 0 | 0 | 0 | 2 489 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 489 | 0 | 0 | 2 489 |
| Other comprehensive income for the period | 0 | 0 | 0 | 3 | 406 | 191 | 9 | 68 - |
19 - |
3 | 119 | 1 - |
640 | 637 | 0 | 0 | 637 |
| Subtotal | 0 | 0 | 0 | 2 486 | 406 | 191 | 9 | 68 - |
19 - |
3 | 119 | 1 - |
640 | 3 126 | 0 | 0 | 3 126 |
| Dividends | 0 | 0 | 0 - 1457 | 0 | 0 | 0 | O | 0 | O | 0 | 0 | 0 | - 1 457 | 0 | 0 - 1 457 | ||
| Coupon on AT1 | 0 | 0 | 0 | 52 | 0 | 0 | 0 | 0 | 0 | O | 0 | 0 | 0 | 52 | 0 | 0 | 52 |
| Issue/repurchase of AT1 included in equity | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 900 - |
0 | 902 |
| Capital increase | 1 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 0 | 0 | 16 |
| Transfer from revaluation reserves to retained earnings on realisation | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | O | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Total change | 1 | 15 | 0 | 974 | 406 | 191 | 10 | 68 - |
19 - |
3 | 119 | 1 - |
641 | 1 632 | 900 | 0 | 732 |
| Balance at the end of the period | 1 458 | 5 498 | 2 | 11 875 | 992 | 350 | 32 | - 1331 | 92 - |
89 | 0 | 4 - |
37 | 48 865 | 1 500 | 0 | 20 365 |
| of which relating to the equity method | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 |
| (in millions of EUR) | Issued and paid up share capital |
premium | Share Treasury Retained shares earnings |
Revalu ation reserv (FVOC deb instru- ments) |
Revalu- ation reserv (FVP equit instru ments overla) |
Revalu- ation reserve (FVOC equit instru ments) |
Hedging reserve (cash flow hedges) |
Trans- lation diffe- rences |
Hedge of Remeas- net invest- ments in foreign opera-tions |
urement of defined benefit plans |
Own credit risk through OCI |
Tota revaluation reserves |
Paren share equity |
Additional tier- included in equity |
Minority nterests |
Total equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31-03-2019 | ||||||||||||||||
| Balance at the end of the previous period | 1 457 | 5 482 | 10 901 ని |
586 | 159 | 22 | - 1 263 | 73 | કર | 119 | 3 | ୧୦୧ | 17 233 | 2 400 | o | 19 633 |
| Net result for the period | 430 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 430 | 0 | 0 | 430 | |||
| OCI for the period | 0 | 0 | 192 | 121 | ర్ | 65 | 2 | 29 | 2 | 276 | 278 | 0 | 0 | 278 | ||
| Subtotal | 0 | 431 0 |
192 | 121 | റ് | 65 ' |
8 | 2 | 29 | 2 | 276 | 708 | 0 | 0 | 708 | |
| Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
| Coupon on AT1 | 0 | 14 ' |
O | 0 | 0 | 0 | 0 | 14 | 0 | 0 | 14 י |
|||||
| Issue/repurchase of AT1 included in equity | 0 | 0 | O | 0 | 0 | 0 | 0 | 900 | 0 | 902 | ||||||
| Transfer from revaluation reserves to retained earnings on realisation | 0 | 0 | 0 | 0 | 0 | 0 | O | 0 | 0 | 0 | 1 | |||||
| Total change | 415 0 |
192 | 121 | 6 | 65 - |
2 | 29 | 276 | 691 | 900 | o | 209 | ||||
| Balance at the end of the period | 1 457 | 5 482 | 11 316 3 |
778 | 281 | 29 | - 1328 | 81 | 88 | 89 | б | 328 | 17 924 | 1 500 | 0 | 19 424 |
| of which relating to application of the equity method | 4 | 0 | 0 | 0 | 13 | 0 | 0 | 0 | 18 | 18 | 18 |
Please note that, fully in line with the European Central Bank recommendation, the KBC Board of Directors has decided :
The 'Dividends' item in 2019 includes:
The line 'Issue or Call of additional Tier-1 instruments included in equity' in 2019 includes:
| (in millions of EUR) | Note (1) | 1Q 2020 | 1Q 2019 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Consolidated income | |||
| Result before tax | statement | - 3 | |
| Adjustments for non-cash items in profit & loss | 1 071 | ||
| Changes in operating assets (excluding cash and cash equivalents) | - 11 694 | ||
| Changes in operating liabilities (excluding cash and cash equivalents) | 10 928 | ||
| Income taxes paid | - 195 | ||
| Net cash from or used in operating activities | 107 | 5 539 | |
| INVESTING ACTIVITIES | |||
| Purchase and proceeds of debt securities at amortised cost | 4.1 | - 1 443 | |
| Acquisition of a subsidiary or a business unit, net of cash acquired (including | |||
| increases in percentage interest held) | 0 | ||
| Proceeds from the disposal of a subsidiary or business unit, net of cash disposed of | |||
| (including decreases in percentage interest held) | O | ||
| Purchase and proceeds from the sale of intangible fixed assets (excluding goodwill) | - 57 | ||
| Purchase and proceeds from the sale of property, plant and equipment (excluding | |||
| goodwill) | 40 | ||
| Other | - 10 | ||
| Net cash from or used in investing activities | - 1 470 | - 391 | |
| FINANCING ACTIVITIES | |||
| Consolidated | |||
| Purchase or sale of treasury shares | statement of changes | 0 | |
| Issue or repayment of promissory notes and other debt securities | 4.1 | 313 | |
| Proceeds from or repayment of subordinated liabilities | 4.1 | - 35 | |
| Principal payments under finance lease obligations | O | ||
| Consolidated | |||
| statement of changes | |||
| Proceeds from the issuance of share capital | in equity | O | |
| Consolidated | |||
| Issue of additional tier-1 instruments | statement of changes | 0 | |
| in equity Consolidated |
|||
| statement of changes | |||
| Proceeds from the issuance of preference shares | in equity | 0 | |
| Consolidated | |||
| statement of changes | |||
| Dividends paid | in equity | 0 | |
| Consolidated | |||
| Coupon additional Tier-1 instruments | statement of changes in equity |
- 9 | |
| Net cash from or used in financing activities | 270 | - 647 | |
| (in millions of EUR) | Note (1) | 1Q 2020 | 1Q 2019 |
|---|---|---|---|
| CHANGE IN CASH AND CASH EQUIVALENTS | |||
| Net increase or decrease in cash and cash equivalents | - 1 093 | 4 501 | |
| Cash and cash equivalents at the beginning of the period | 1 | 29 118 | 34 354 |
| Effects of exchange rate changes on opening cash and cash equivalents | - 1 842 | 64 - |
|
| Cash and cash equivalents at the end of the period | 26 183 | 38 790 | |
| COMPONENTS OF CASH AND CASH EQUIVALENTS | |||
| Cash and cash balances with central banks and other demand deposits with credit institutions |
Consolidated balance sheet |
7 489 | 16 967 |
| Term loans to banks at not more than three months (excl. reverse repos) Reverse repos with credit institutions and investment firms at not more than three |
4.1 | 559 | 1 075 |
| months | 4.1 | 26 397 | 27 146 |
| Deposits from banks repayable on demand | 4.1 | - 8 261 | - 6 398 |
| Cash and cash equivalents belonging to disposal groups | O | O | |
| Total | 26 183 | 38 790 | |
| of which not available | O | O |
As of 2020, we provide additional details on the cash flow statement in the interim reporting (not retroactively).
The net cash from operating activities in 1Q 2020 was limited (+107 million euros) as the growth of the deposits was at a similar level as the loan growth. In 1Q 2019, the positive net cash from operating activities (+5 539 million euros) is mainly thanks to relative higher deposit growth (incl. higher demand deposits and saving accounts).
Net cash from (used in) investing activities in 1Q 2020 and 1Q 2019 (respectively -1 470 and -391 million euros) is mainly explained by additional investments in debt securities at amortised cost.
The net cash flow from financing activities in 1Q 2020 (+270 million euros) mainly includes the issue of Senior Holdco instruments for 500 million euros, partly offset by repayments. In 1Q 2019 the net cash flow from financing activities (-647 million euros) includes the call by KBC Group NV of Additional Tier-1 instruments that had been issued in 2014, with a nominal value of 1.4 billion euros and the issue of Additional Tier-1 instruments included in equity for 500 million euros.
The condensed interim financial statements of the KBC Group for the period ended 31 March 2020 have been prepared in accordance with IAS 34, 'Interim financial reporting'. The condensed interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2019, which have been prepared in accordance with the International Financial Reporting Standards as adopted for use in the European Union ('endorsed IFRS').
The following IFRS standards became effective on 1 January 2020 and have been applied in this report:
The following IFRS standards were issued but not yet effective in 2020. KBC will apply these standards when they become mandatory.
A summary of the main accounting policies is provided in the group's annual accounts as at 31 December 2019.
Exchange rates used: during the first quarter of 2020, the exchange rates of the CZK and HUF dropped significantly, with negative impact on the balance sheet total (versus limited impact for the average rate used for the income statement).
The growing public health crisis around the world has distressed financial markets amid concerns that the global economy, and the EU's economies in particular, are heading towards a sharp contraction in the second quarter of 2020 and for full year 2020. The coronavirus pandemic has triggered a chain of events in the markets that has led to a massive sell-off across asset classes and a sharp increase in volatility.
The significant deterioration in the economic outlook has brought about an unprecedented monetary policy response from central banks and governments around the world, resulting in flattening yield curves and widening credit spreads.
| Belgium | Czech Republic | Slovakia | Hungary | Bulgaria | Ireland | |
|---|---|---|---|---|---|---|
| Deferral of payments |
• Opt-in: 6 months, (maximum until 31 Oct 2020) • Applicable for mortgages and viable companies • For private persons: deferral of principal and interest, while only capital deferral for commercial clients • Interest is accrued over deferral period, with the exception of families with net income less than 1,700 euros. For the latter group, this results in a modification loss for the bank (est. in 2Q) |
• Opt-in: 3 or 6 months • Applicable for retail and non-retail clients • For private persons: deferral of principal and interest, while only capital deferral for commercial clients • Interest is accrued over the deferral period, but the interest has to be repaid in the last instalment, resulting in a small modification loss for the bank (est. in 2Q) • For consumer loans, the interest during the deferral period cannot exceed 2-week repo rate + 8% |
• Opt-in: 9 months or 6 months (for leases) • Applicable for retail customers, entrepreneurs and SMEs • Deferral of principal and interest • Interest is accrued over the deferral period, but the client has the option to repay all interests at once after the moratorium or repay on a linear basis. The latter option would result in a small modification loss for the bank (est. in 2Q) |
• Opt-out: a blanket moratorium until 31 Dec 2020 • Applicable for retail and non-retail cients • Deferral of principal and interest • Interest is accrued over deferral period, but unpaid interest cannot be capitalized and must be collected on a linear way during the remaining (extended) lifetime. This results in a modification loss for the bank (estimated at -18 million euros, booked in 1Q) |
• Opt-in: 6 months (maximum until 31 December 2020 • Applicable for retail and non- retail • Deferral of principal and interest • Interest is accrued over deferral period |
• Opt-in: 3 to 6 months • Applicable for mortgage loans, consumer finance loans and business banking loans with repayment schedule • Deferral of principal and interests for up to 6 months (with revision after 3 months) for Mortgages & Consumer finance and 3 months for business banking Interest is accrued over • deferral period, but repaid on linear basis, resulting in a modification loss for the bank (est. in 2Q) |
| Guarantee scheme & Liquidity assistance |
• A state guarantee scheme up to 50 billion euros to cover losses incurred on future loans granted before 30 September 2020 to viable companies, with a tenor of maximum 12 months. Guarantee covers 50% of losses above 3% of total credit losses and 80% above 5% of losses • New loans with a maturity of 12 months under the government guarantee scheme (leasing and factoring excluded), with maximum interest of 1.25% |
• Providing a guarantee for company loans (up to 80%, maximum amount of the loan up to 548 000 euros) from commercial banks, sponsored by Czech-Moravian Guarantee and Development Bank • Interest-free loans provided by the Czech-Moravian Guarantee and Development bank to entrepreneurs and SMEs ranging from 18 000 to 548 000 euros, up to 2 year maturity including a 12 months grace period |
• State offers bank guarantees of up to 500 million euros a month to commercial clients • Working capital loans aimed at helping SMEs in particular to bridge this period (loan amount up to 500 000 euros, with 3 years maturity including a 12 months grace period), in preparation by EXIM Bank of the Slovak Republic • Proposal for banks to grant Short term interest-free loans to companies guaranteed by SZRB |
• Already existing government guarantee scheme (Garantiqa) is largely extended to cope with Covid-19 crisis • Annual interest rate on personal loans granted by commercial banks may not exceed the central bank base rate by more than 5 percentage points |
• 700 million BGN of state guarantees provided by the Bulgarian Development Bank to commercial banks of which 100 million euros provided for an interest-free personal loan up to 750 euros |
• A credit guarantee scheme will be provided by the pillar banks to affected firms. Loans of up to 1 million euros will be available (estimated at 150 million euros) • A 200 million euros in liquidity support for struggling firms made available by Enterprise Ireland • Working capital and long-term loans (up to 1.5 million euros) will be provided by the Strategic Banking Corporation of Ireland's Covid-19 Working Capital Scheme at reduced rates, totaling 650 million euros |
Our 1Q20 collective Expected Credit Losses (ECL) calculations are based on pre-Covid-19 macroeconomics. The ECL models are not able to adequately reflect the specificities of the Covid-19 crisis nor the various government measures implemented in the different countries to support households, SME's and Corporates through this crisis. Therefore, an expert-based calculation on portfolio level has been performed to take into account the adjusted macroeconomic circumstances and the different government measures via a management overlay. For this purpose a methodology has been devised to apply a certain stress to the performing portfolio by end of March 2020 which is fully explained in this note.
The methodology applied for determining the Covid-19 impact starts from the forecast of the KBC Group Chief Economist of end of 1Q 2020 (see paragraph Economic scenarios below for more details on these forecasts). For each of our home countries, these scenarios – which take into account the different local government measures – were translated together with the KBC Chief Economist into certain PD downgrades (between 1 and 3 notches1), under the assumption that higher PDs will be more affected. In general the assumption was taken that on average SME would be more vulnerable than corporates. Next to the above, and in line with the ECB/ESMA/EBA guidance, any general government measure has not led to an automatic staging in the applied portfolio stress.
Based on expert opinion, only a certain number of (sub)sectors, which we believe will be mainly affected by Covid-19, are included in the 1Q management overlay. These consist in the aggregate of (in descending order of importance in terms of ECL):
These (sub)sectors represent about 5,2% of our total corporate and SME portfolio. Our loan and investment portfolio banking (as defined in the annual accounts of 2019 in the chapter 'How do we manage our risks?') is as follows:
| (in billions of EUR) | 31-03-2020 31-12-2019 | |
|---|---|---|
| Portfolio outstanding | 180 | 175 |
| Retail | 40% | 42% |
| of which mortgages | 37% | 38% |
| of which consumer finance | 3% | 3% |
| SME | 21% | 22% |
| Corporate | 39% | 37% |
For the management overlay (fully assigned to stage 2) we attributed 100% weight to the base scenario, given that we currently believe that this is the most likely scenario. In terms of impact, this results in the following amounts (in millions of EUR):
| Sector | BE | CZ | HU | SK | In % of total Total corporate & SME loan portfolio |
|
|---|---|---|---|---|---|---|
| Distribution - retail | 12.6 | 4.3 | 0.9 | 1.0 | 18.8 | 2,1 |
| Hotels, bars & restaurants | 16.0 | 1.1 | 0.2 | 0.0 | 17,4 | 1.0 |
| Shipping - transportation | 3.3 | 0.1 | 0.1 | 0.0 | 3.4 | 1,2 |
| Services - entertainment & leisure | 3.0 | 0.3 | 0.1 | 0.0 | 3.4 | 0.7 |
| Aviation | 0,2 | 0,2 | 0.0 | 0.0 | 0.4 | 0.3 |
| Total | 35,1 | 5.9 | 1,3 | 1.0 | 43.3 | 5,2 |
The impact for United Bulgarian Bank AD (Bulgaria) and KBC Bank Ireland Plc. is currently deemed immaterial for Q1.
The credit cost ratio (CCR) including this impact increases from 0,12% per FY19 to 0,27% per 1Q20.
The retail portfolio is not included in the above management overlay, as it is our current stance that the government measures (known and possible additional ones in the spirit that governments will do everything it takes to minimize the negative impact especially for retail customers) will prevent any significant impact on the retail portfolios.
1 A 1 notch downgrade represents doubling of the probability of default.
As a result of the coronavirus pandemic, we estimate the full-year 2020 Impairments at roughly 1.1 billion euros (base scenario). Depending on a number of events such as the length and depth of the economic downturn, the significant number of government measures in each of our core countries, some of which still need to be worked out in detail, and the unknown amount of customers who will call upon these mitigating actions, we estimate the full-year 2020 impairment to range between roughly 0.8 billion euros (optimistic scenario) and roughly 1.6 billion euros (pessimistic scenario).
Regarding CET1, in line with the ECB recommendation we intend to apply (subject to ECB approval) the IFRS 9 transitional measures going forward.
The KBC Group Chief Economist has formulated three different forecasts that differ on the virus evolution and its impact on the lockdown measures in the different home countries. In short the three scenarios can be summarized as follows:
| Scenario | Virus evolution | Lockdown evolution | Economy | Recovery |
|---|---|---|---|---|
| Optimistic | Spread quickly under control |
Lifted fast in Q2 | Fall in 1H20, steep recovery from Q3 onwards |
Sharp, short V-shaped pattern |
| Base | Spread under control thanks to longer ockdown |
Slow and gradual removal from Q3 onwards |
Major fall in economic activity in 1H20 with gradual recovery in 2H20 |
Pronounced V/U-shaped pattern |
| Pessimistic | Spread continues until vaccination |
On-off until vaccination | Long-term stagnation and negative growth |
W/L-pattern with right leg only slowly increasing |
Within the base scenario, demand (consumer spending) and supply (people & resources) are expected to be severely hit in 2020, with the current financial condition of the companies/private persons mainly determining whether they will be able to weather the storm or not, also taking into account the government measures to support (viable) companies and private persons.
The following table gives these scenarios for three key indicators (GDP growth, unemployment rate and house price index) for each of our core countries for the next three years. After that, we take into account a gradual linear transition towards a steady state.
| Macroeconomic base scenario - key indicators* (situation at March 31, 2020) |
2020 | 2021 | 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Scenario Optimistic | Base | Pessimistic Optimistic | Base | Pessimistic Optimistic | Base Pessimistic | ||||
| Real GDP growth | |||||||||
| Euro area | -6,0% | -11,3% | -14.0% | 6,5% | 11,0% | -3,2% | 1,3% | 1,2% | 5.0% |
| Belgium | -5.0% | -9.5% | -13.2% | 6.0% | 12.3% | -3.2% | 1,3% | 1.3% | 5.0% |
| Czech Republic | -5.0% | -10,0% | -15,0% | 2.0% | 4.0% | 0.0% | 2,1% | 2,0% | 3,0% |
| Hungary | -3.0% | -9.0% | -12.0% | 2,0% | 4.0% | 1.0% | 3,0% | 3.0% | 3.0% |
| Slovakia | -5,0% | -10,0% | -14,0% | 2,5% | 5,0% | -2,5% | 2,6% | 2,5% | 2,5% |
| Bulgaria | -4.0% | -10.0% | -12.0% | 3,0% | 5,0% | 2.0% | 3,0% | 3.0% | 3.0% |
| Ireland | -2.0% | -5.0% | -10.0% | 2.0% | 4.0% | 1.0% | 2,6% | 3.5% | 2.5% |
| Unemployment rate | |||||||||
| Belgium | 5,9% | 6,2% | 10,0% | 5,8% | 5,8% | 12,0% | 5,6% | 5,6% | 9,5% |
| Czech Republic | 3,5% | 4.5% | 5.5% | 4,0% | 5.5% | 7,0% | 3,7% | 5,0% | 7,0% |
| Hungary | 5,7% | 7,2% | 12,0% | 4,4% | 5,0% | 8.7% | 4,0% | 4,3% | 5,9% |
| Slovakia | 8,0% | 9.0% | 12.0% | 9,3% | 11.0% | 14.0% | 7,7% | 8,0% | 14.0% |
| Bulgaria | 6.8% | 8.0% | 11.0% | 7.7% | 10.0% | 13.0% | 6.1% | 7.0% | 12.0% |
| Ire and | 9,7% | 14,0% | 20,0% | 7,1% | 9,0% | 18,0% | 5,6% | 6,0% | 12,0% |
| House price index | |||||||||
| Belgium | -1.0% | -3.0% | -6.0% | 0.0% | -2.0% | -4.0% | 1,5% | 1.0% | -1.0% |
| Czech Republic | 0.0% | -2.0% | -4.0% | -0.8% | -3.5% | -6.0% | 2,0% | 2.0% | 0.0% |
| Hungary | -1.0% | -5.0% | -7.5% | 0.0% | -3.0% | -5,0% | 2,5% | 2.0% | 1.0% |
| Slovakia | -1,0% | -5,0% | -7,0% | 0,5% | -2,0% | -3,0% | 2,0% | 2,0% | 1.0% |
| Bulgaria | 0,5% | -2,0% | -4,0% | 1,0% | -1,0% | -3,0% | 3,0% | 3,0% | 0,0% |
| reland | -6.0% | -12,0% | -20,0% | 5,0% | 8.0% | -5,0% | 4,0% | 5,0% | 3.0% |
Financial instruments at fair value through P&L have been affected by the increased volatility in financial markets. The combination of a number of market-driven factors, such as sharply lower stock markets, widening credit spreads and lower long-term interest rates, has had a negative impact on the fair value of financial Instruments at KBC of 0.4 billion euros. For more information: see note 3.3 further in this report.
We have performed an ad-hoc assessment of goodwill impairment indication. The outcome shows no indication of impairment.
We have investigated whether it is probable that taxable profit will be available against which the deductible temporary differences can be utilised based on projections for a period of eight to ten years. The conclusion of this analysis is that there are sufficient estimated taxable profits available.
The impact of Covid-19 on the financial markets is also reflected in a downward movement of the revaluation reserves in OCI, more specifically on the revaluation reserve (FVPL equity instruments) – overlay approach, revaluation reserve (FVOCI debt instruments) and the translation differences. For more information, see text below the table Other Comprehensive income.
Insurance contracts:
The impact in 1Q 2020 related to Corona is limited.
Impact on the acquisition of OTP Banka Slovensko and the sale of NLB Vita: The approval processes for both files are still ongoing.
For a description on the management structure and linked reporting presentation, reference is made to note 2.1 in the annual accounts 2019.
| Czech | International | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Belgium Business |
Republic Business |
Markets | Business Of which: | Group | |||||
| (in millions of EUR) | unit | unit | unit | Hungary Slovakia | Bulgaria Ireland Centre | Total | |||
| 1Q2020 | |||||||||
| Net interest income | 640 | 351 | 219 | 62 | 50 | રૂણ | 71 | - 16 | 1 195 |
| Non-life insurance (before reinsurance) | 112 | 31 | 40 | 14 | 7 | 18 | 0 | 2 | 185 |
| Earned premiums | 283 | 75 | 82 | 39 | 12 | 31 | 0 | 2 | 443 |
| Technical charges | - 172 | - 44 | 43 - |
25 - |
- 5 | - 13 | 0 | 0 | 258 - |
| Life insurance (before reinsurance) | - 21 | 14 | రి | 1 | 3 | 4 | 0 | 0 | 0 |
| Earned premiums | 216 | 52 | 29 | 9 | 9 | 11 | 0 | 0 | 297 |
| Technical charges | - 237 | - 39 | - 21 | 8 - |
- 7 | - 7 | 0 | 0 | 297 |
| Ceded reinsurance result | - 9 | 0 | - 3 | - 1 | 0 | 2 - |
0 | 5 | - 7 |
| Dividend income | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 12 |
| Net result from financial instruments at fair value through profit or loss | - 217 | - 125 | - 5 | 2 | - 8 | 0 | 2 | - 39 | 385 |
| Net realised result from debt instruments at fair value through OCI | O | O | 0 | 0 | O | 0 | 0 | 0 | 0 |
| Net fee and commission income | 308 | ર્સ્ટ | ലെ | 49 | 15 | ರಿ | - 1 | - 2 | 429 |
| Net other income | 35 | 9 | ರಾ | 2 | 3 | 0 | 0 | 0 | 20 |
| TOTAL INCOME | 858 | 335 | 333 | 130 | 70 | 62 | 71 | - 48 | |
| 1 479 | |||||||||
| Operating expenses | - 828 | - 221 | - 268 | - 101 | - 59 | - 48 | - 60 | - 21 | - 1 338 |
| Impairment | - 117 | - 9 | - 24 | - 16 | - 6 | - 3 | 2 | 9 | - 141 |
| on financial assets at amortised cost and at fair value through OCI | - 116 | - 8 | - 6 | 2 | - 6 | - 3 | 1 | 9 | 121 |
| on goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other | 0 | - 1 | 18 - |
18 - |
0 | 0 | 0 | 0 | 20 - |
| Share in results of associated companies and joint ventures | 3 - |
0 | 0 | 0 | 0 | 0 | 0 | 0 | - 3 |
| RESULT BEFORE TAX | 90 - |
105 | 42 | 13 | 4 | 11 | 13 | - 60 | - 3 |
| Income tax expense | 4 | - 17 | - 7 | - 4 | - 1 | - 1 | - 2 | 18 | - 2 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT AFTER TAX | 86 - |
88 | રૂડ | 10 | 4 | 10 | 12 | - 43 | - 5 |
| attributable to minority interests | 0 | O | 0 | O | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | - 86 | 88 | 35 | 10 | 4 | 10 | 12 | - 43 | - 5 |
| 1Q2019 | |||||||||
| Net interest income | 625 | 302 | 213 | 62 | 52 | રૂડે | રેર | - 11 | 1 129 |
| Non-life insurance (before reinsurance) | 04 | 29 | રૂડે | 12 | 7 | 16 | 0 | చి | 161 |
| Earned premiums | 270 | ୧୧ | 77 | 37 | 11 | 29 | 0 | 2 | 415 |
| Technical charges | - 175 | 37 l |
42 - |
26 - |
- 4 | - 12 | 0 | 1 | 254 |
| Life insurance (before reinsurance) | - 25 | 14 | 9 | 2 | 3 | 4 | 0 | 0 | - 3 |
| Earned premiums | 268 | 56 | 27 | 4 | 11 | 11 | 0 | 0 | 351 |
| Technical charges | - 293 | - 42 | - 18 | - 3 | - 8 | - 7 | 0 | 0 | 354 - |
| Ceded reinsurance result | రి | - 3 | - 2 | - 1 | 0 | 2 - |
0 | - 10 | - 7 |
| Dividend income | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 12 |
| Net result from financial instruments at fair value through profit or loss | 54 | - 3 | 10 | 10 | 0 | 4 | રે - |
રૂક | ਰੇਰੇ |
| 0 | 0 | 1 | 0 | 0 | 0 | 0 | |||
| Net realised result from debt instruments at fair value through OCI | 286 | રૂક | ୧୫ | 48 | 1 15 |
ರಿ | - 1 | 2 - |
2 |
| Net fee and commission income Net other income |
3 | 1 | 2 | 0 | 0 | - 2 | 410 | ||
| 45 | 13 | રુવ | |||||||
| TOTAL INCOME | 1 099 | 410 | 336 | 133 | 80 | ਦੇਤੋ | 60 | 17 | 1 862 |
| Operating expenses | - 807 | - 204 | - 260 | - 102 | 55 - |
47 - |
- 56 | - 24 | - 1 296 |
| Impairment | - 83 | 1 | 7 | 0 | - 3 | - 2 | 12 | 6 | - 69 |
| on financial assets at amortised cost and at fair value through OCI | 82 - |
2 | 8 | 0 | 3 - |
2 | 12 | 6 | - 67 |
| on goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other | - 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 1 |
| Share in results of associated companies and joint ventures | - 1 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 5 |
| RESULT BEFORE TAX | 208 | 212 | 85 | 31 | 23 | 15 | 16 | 2 - |
503 |
| Income tax expense | - 32 | - 35 | - 15 | ଚ - |
- 5 | 2 - |
- 2 | 9 | - 73 |
| Net post-tax result from discontinued operations | 0 | 0 | O | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT AFTER TAX | 176 | 177 | 70 | 25 | 18 | 13 | 14 | 7 | 430 |
| attributable to minority interests | O | 0 | O | 0 | O | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 176 | 177 | 70 | 25 | 18 | 13 | 14 | / | 430 |
| (in millions of EUR) | 1Q 2020 | 4Q 2019 | 1Q 2019 |
|---|---|---|---|
| Total | 1 195 | 1 182 | 1 129 |
| Interest income | 1 936 | 1 809 | 1 821 |
| Interest income on financial instruments calculated using the effective interest rate method | |||
| Financial assets at AC | 1 386 | 1 389 | 1 360 |
| Financial assets at FVOCI | 83 | 83 | 88 |
| Hedging derivatives | 134 | 107 | 119 |
| Financial liabilities (negative interest) | 20 | 14 | 13 |
| Other | ന | ব | ട |
| Interest income on other financial instruments | |||
| Financial assets MFVPL other than held for trading | 3 | 3 | 1 |
| Financial assets held for trading | 307 | 210 | 233 |
| Of which economic hedges | 298 | 203 | 226 |
| Other financial assets at FVPL | O | O | O |
| Interest expense | - 741 | - 627 | - 692 |
| Interest expense on financial instruments calculated using the effective interest rate method | |||
| Financial liabilities at AC | - 284 | - 311 | - 340 |
| Financial assets (negative interest) | - 10 | - 10 | - 24 |
| Hedging derivatives | - 177 | - 166 | - 164 |
| Other | - 2 | - 2 | - 1 |
| Interest expense on other financial instruments | |||
| Financial liabilities held for trading | - 257 | - 127 | - 152 |
| Of which economic hedges | - 247 | - 117 | - 144 |
| Other financial liabilities at FVPL | - 10 | - 10 | - 9 |
| Net interest expense relating to defined benefit plans | - 1 | - 2 | - 2 |
The vast majority of negative interest on financial liabilities and financial assets relates to transactions with central banks, interbank and professional counterparties as well as the TLTRO.
Financial instruments at fair value through profit or loss have been affected by the increased volatility in financial markets, largely related to the Covid-19 crisis.
The result from financial instruments at fair value through profit or loss in 1Q 2020 is 515 million euros lower compared to 4Q 2019. The quarter-on-quarter decrease is due to:
Compared to 1Q 2019, the result from financial instruments at fair value through profit or loss is 484 million euros lower in 1Q 2020, for a large part explained by:
| (in millions of EUR) | 1Q 2020 | 4Q 2019 | 1Q 2019 |
|---|---|---|---|
| Total | 429 | 445 | 410 |
| Fee and commission income | 628 | 643 | 588 |
| Fee and commission expense | - 199 | 198 | 178 |
| Breakdown by type | |||
| Asset Management Services | 270 | 279 | 264 |
| Fee and commission income | 285 | 295 | 277 |
| Fee and commission expense | - 15 | - 16 | - 13 |
| Banking Services | 229 | 243 | 219 |
| Fee and commission income | 319 | 331 | 294 |
| Fee and commission expense | - 90 | - 87 | 76 |
| Distribution | 71 | 77 | 73 |
| Fee and commission income | 24 | 17 | 16 |
| Fee and commission expense | - 95 | ે છે ર | 89 |
| (in millions of EUR) | 1Q 2020 | 4Q 2019 | 1Q 2019 |
|---|---|---|---|
| Total | 50 | 47 | 59 |
| of which gains or losses on | |||
| Sale of financial assets measured at amortised cost | 8 | ব | ന |
| Repurchase of financial liabilities measured at amortised cost | O | O | O |
| of which other, including: | 42 | 44 | 55 |
| Income from (mainly operational) leasing activities, KBC Lease Group | 19 | 16 | 19 |
| Income from VAB Group | 12 | 8 | 11 |
| Settlement of legacy legal cases | O | O | റ |
| Provisioning for tracker mortgage review | O | - | 0 |
Note : Settlement of legacy legal cases concerns Czech Republic (+6 million euros in 1Q 2019)
| (in millions of EUR) | Life | Non-life | Non- technical account |
Total |
|---|---|---|---|---|
| 1Q 2020 | ||||
| Earned premiums, insurance (before reinsurance) | 297 | 448 | 745 | |
| of which change in provision unearned premiums | - 1 | - 230 | - 232 | |
| Technical charges, insurance (before reinsurance) | - 297 | - 259 | - 556 | |
| Claims paid | - 268 | - 234 | - 502 | |
| Changes in technical provisions | 47 | - 8 | 39 | |
| Other technical result | - 76 | - 17 | - 93 | |
| Net fee and commission income | 2 | - 87 | - 85 | |
| Ceded reinsurance result | 4 | - 12 | - 7 | |
| General administrative expenses | - 48 | - 63 | 1 - |
- 112 |
| Internal claims settlement expenses | - 2 | - 15 | - 17 | |
| Indirect acquisition costs | - 8 | - 18 | - 27 | |
| Administrative expenses | - 38 | - 30 | - 68 | |
| Investment management fees | 0 | O | 1 l |
- 1 |
| Technical result | - 42 | 27 | 1 - |
- 16 |
| Investment Income (*) | 22 | ರಿ | 6 | 37 |
| Technical-financial result | - 20 | રૂદિ | 5 | 21 |
| Share in results of associated companies and joint ventures |
||||
| RESULT BEFORE TAX | - 20 | રૂદિ | 5 | 21 |
| Income tax expense | - 18 | |||
| RESULT AFTER TAX | 3 | |||
| attributable to minority interest | O | |||
| attributable to equity holders of the parent |
3 | |||
| 1Q 2019 | ||||
| Earned premiums, insurance (before reinsurance) | 351 | 420 | 771 | |
| of which change in provision unearned premiums | - 1 | - 220 | - 220 | |
| Technical charges, insurance (before reinsurance) | - 354 | - 255 | - 608 | |
| Claims paid | - 292 | - 211 | - 502 | |
| Changes in technical provisions | - 89 | - 27 | - 117 | |
| Other technical result | 27 | - 17 | 10 | |
| Net fee and commission income | - 7 | - 84 | - 91 | |
| Ceded reinsurance result | O | - 7 | - 7 | |
| General administrative expenses | - 49 | - 64 | 1 - |
- 113 |
| Internal claims settlement expenses | - 2 | - 15 | - 17 | |
| Indirect acquisition costs | - 8 | - 18 | - 25 | |
| Administrative expenses | - 39 | - 31 | - 70 | |
| Investment management fees | 1 - |
- 1 | ||
| Technical result | - 58 | 11 | - 1 | - 48 |
| Investment Income (*) | 126 | 22 | 11 | 159 |
| Technical-financial result | દક | રૂઝ | 10 | 110 |
| Share in results of associated companies and joint ventures |
1 | 1 | ||
| RESULT BEFORE TAX | ୧୫ | 33 | 12 | 112 |
| Income tax expense | - | - | - | - 15 |
| RESULT AFTER TAX | - | - | - | 97 |
| attributable to minority interest | 0 | |||
| attributable to equity holders of the parent |
96 |
(*)1Q 2020 consists of (in millions of EUR): Net interest income (111), Net Dividend income (7), Net result from financial instruments at fair value through profit and loss (-79) and Impairment (-2).
1Q 2019 consists of (in millions of EUR): Net interest income (118), Net Dividend income (7), Net result from financial instruments at fair value through profit and loss (32), Net realised result from debt instruments at fair value through OCI (1), Net other income (1) and Impairment (0). The non-technical account includes also results of non-insurance companies such as VAB group and ADD.
Note: Figures for premiums exclude the investment contracts without DPF (Discretionary Participation Features), which roughly coincide with the unit-linked products. Figures are before elimination of transactions between the bank and insurance entities of the group (more information in the 2019 annual accounts).
In 1Q 2020 the technical result non-life was negatively impacted by :
• Storms in Belgium, Czech Republic and Hungary for an amount of -51 million euros (pre-tax, before reinsurance)
In 1Q 2019 the technical result non-life was negatively impacted by
The operating expenses for 1Q 2020 include 407 million euros related to bank (and insurance) levies (51 million euros in 4Q 2019; 382 million euros in 1Q 2019). Application of IFRIC 21 (Levies) has as a consequence that certain levies are taken upfront in expense of the first quarter of the year.
| (in millions of EUR) | 1Q 2020 | 4Q 2019 | 1Q 2019 |
|---|---|---|---|
| Total | - 141 | - 82 | - 69 |
| Impairment on financial assets at AC and at FVOCI | - 121 | - 75 | - 67 |
| Of which impairment on financial assets at AC | - 120 | - 75 | - 68 |
| By product | |||
| Loans and advances | - 111 | - 68 | - 62 |
| Debt securities | O | O | |
| Off-balance-sheet commitments and financial guarantees | - 9 | 7 - |
5 |
| By type | |||
| Stage 1 (12-month ECL) | - 8 | 5 | 2 |
| Stage 2 (lifetime ECL) | - 46 | 37 | 8 |
| Stage 3 (non-performing; lifetime ECL) | - 65 | - 118 | - 70 |
| Purchased or originated credit impaired assets | 1 - |
1 | 3 |
| Of which impairment on financial assets at FVOCI | - 1 | O | O |
| Debt securities | 1 - |
O | O |
| Stage 1 (12-month ECL) | O | O | 1 - |
| Stage 2 (lifetime ECL) | 1 - |
O | 1 |
| Stage 3 (non-performing; lifetime ECL) | O | O | 0 |
| Impairment on goodwill | O | O | 0 |
| Impairment on other | - 20 | / - |
|
| Intangible fixed assets (other than goodwill) | O | 3 - |
O |
| Property, plant and equipment (including investment property) | O | 2 | 0 |
| Associated companies and joint ventures | O | O | O |
| Other | - 19 | 3 - |
The stage 2 impairments include 43 million euros management overlay for collective ECL related to COVID-19. For more information, see note 1.4 of this report.
The stage 3 impairments in 1Q 2020 and 1Q 2019 are attributable mainly to loan loss impairments in Belgium due to a number of corporate files.
The impairment on other – Other include -18 million euros related to modification losses in Hungary. For more information, see note 1.4 of this report.
| MFVPL | ||||||||
|---|---|---|---|---|---|---|---|---|
| excl. HFT |
||||||||
| and | Hedging deriva- |
|||||||
| (in millions of EUR) | AC | FVOCI overlay | Overlay | HFT | FVO | tives | Total | |
| FINANCIAL ASSETS, 31-03-2020 | ||||||||
| Loans and advances to credit institutions and investment firms (excl. reverse repos) |
6 429 | 0 | 0 | 0 | 0 | 0 | 0 | 6 429 |
| of which repayable on demand and term loans at not more than three months | 559 | |||||||
| Loans and advances to customers (excl. reverse repos) | 158 119 | 0 | 245 | 0 | 0 | 0 | 0 | 158 364 |
| Trade receivables | 1 692 | 0 | 0 | 0 | 0 | 0 | 0 | 1 692 |
| Consumer credit | 5 120 | 0 | 148 | 0 | 0 | 0 | 0 | 5 269 |
| Mortgage loans | 66 812 | 0 | 88 | 0 | 0 | 0 | 0 | 66 900 |
| Term loans | 72 189 | 0 | 9 | 0 | 0 | 0 | 0 | 72 198 |
| Finance lease | 5 815 | 0 | 0 | 0 | 0 | 0 | 0 | 5 815 |
| Current account advances | 5 263 | 0 | 0 | 0 | 0 | 0 | 0 | 5 263 |
| Other | 1 227 | 0 | 0 | 0 | 0 | 0 | 0 | 1 227 |
| Reverse repos | 29 239 | 0 | 0 | 0 | 130 | 0 | 0 | 29 369 |
| with credit institutions and investment firms | 28 854 | 0 | 0 | 0 | 130 | 0 | 0 | 28 984 |
| with customers | 385 | 0 | 0 | 0 | 0 | 0 | 0 | 385 |
| Equity instruments | 0 | 249 | 7 | 1 122 | 482 | 0 | 0 | 1 861 |
| Investment contracts (insurance) | 0 | 0 | 13 092 | 0 | 0 | 0 | 0 | 13 092 |
| Debt securities issued by | 43 868 | 18 178 | 50 | 0 | 3 220 | 0 | 0 | 65 315 |
| Public bodies | 37 636 | 12 034 | 0 | 0 | 3 119 | 0 | 0 | 52 790 |
| Credit institutions and investment firms | 3 726 | 2 658 | 0 | 0 | 21 | 0 | 0 | 6 405 |
| Corporates | 2 506 | 3 486 | 50 | 0 | 79 | 0 | 0 | 6 120 |
| Derivatives | 0 | 0 | 0 | 0 | 7 740 | 0 | 178 | 7 918 |
| Other | 1 235 | 0 | 0 | 0 | 2 | 0 | 0 | 1 238 |
| Total | 238 890 | 18 427 | 13 394 | 1 122 | 11 574 | 0 | 178 | 283 586 |
| FINANCIAL ASSETS, 31-12-2019 | ||||||||
| Loans and advances to credit institutions and investment firms (excl. reverse repos) |
5 398 | 0 | 0 | 0 | 1 | 0 | 0 | 5 399 |
| of which repayable on demand and term loans at not more than three months | 468 | |||||||
| Loans and advances to customers (excl. reverse repos) | 155 598 | O | 218 | 0 | 0 | 0 | O | 155 816 |
| Trade receivables | 1 885 | 0 | 0 | 0 | 0 | 0 | 0 | 1 885 |
| Consumer credit | 5 383 | O | 122 | 0 | 0 | 0 | 0 | ર રેણર |
| Mortgage loans | 67 711 | 0 | 85 | 0 | 0 | 0 | 0 | 67 796 |
| Term loans | 68 867 | O | 10 | 0 | 0 | 0 | 0 | 68 877 |
| Finance lease | 5 926 | O | 0 | 0 | 0 | 0 | 0 | 5 926 |
| Current account advances | 4 979 | 0 | 0 | 0 | 0 | 0 | 0 | 4 979 |
| Other | 847 | O | 0 | 0 | 0 | 0 | 0 | 847 |
| Reverse repos | 25 596 | O | 0 | 0 | 0 | 0 | O | 25 596 |
| with credit institutions and investment firms | 25 445 | 0 | 0 | 0 | 0 | 0 | 0 | 25 445 |
| with customers | 151 | O | 0 | 0 | 0 | 0 | 0 | નરવ |
| Equity instruments | 0 | 249 | 7 | 1 431 | 833 | 0 | 0 | 2 519 |
| Investment contracts (insurance) | 0 | O | 14 584 | 0 | 0 | 0 | O | 14 584 |
| Debt securities issued by | 42 998 | 18 788 | રેક | 0 | 1 269 | 0 | 0 | 63 114 |
| Public bodies | 37 024 | 12 370 | 0 | 0 | 1 149 | 0 | O | 50 542 |
| Credit institutions and investment firms | 3 632 | 2 753 | 0 | 0 | 20 | 0 | 0 | 6 405 |
| Corporates | 2 343 | 3 666 | 58 | 0 | ਰੇਰੇ | 0 | 0 | 6 167 |
| Derivatives | 0 | O | 0 | 0 | 5 163 | 0 | 158 | 5 322 |
| Other | 1 049 | 0 | 0 | 0 | 0 | 0 | 0 | 1 049 |
| Total | 230 639 | 19 037 | 14 867 | 1 431 | 7 266 | O | 158 | 273 399 |
| Hedging | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | AC | HFT | FVO | derivatives | Total |
| FINANCIAL LIABILITIES, 31-03-2020 | |||||
| Deposits from credit institutions and investment firms (excl. repos) |
21 211 | O | 0 | O | 21 211 |
| of which repayable on demand | 8 261 | ||||
| Deposits from customers and debt securities (excl. repos) | 205 826 | 203 | 2 265 | 0 | 208 293 |
| Demand deposits | 89 906 | O | 0 | 0 | 89 906 |
| Time deposits | 14 239 | 42 | 150 | 0 | 14 431 |
| Savings accounts | 68 703 | 0 | 0 | 0 | 68 703 |
| Special deposits | 2 308 | 0 | 0 | 0 | 2 308 |
| Other deposits | 453 | 0 | 0 | 0 | 453 |
| Certificates of deposit | 12 967 | 0 | 7 | 0 | 12 974 |
| Savings certificates | 805 | O | 0 | 0 | 805 |
| Non-convertible bonds | 14 162 | 160 | 1 960 | 0 | 16 282 |
| Non-convertible subordinated liabilities | 2 284 | 0 | 148 | 0 | 2 432 |
| 5 408 | 65 | 0 | 0 | 5 474 | |
| Repos with credit institutions and investment firms |
4 591 | 23 | 0 | 0 | |
| 0 | 4 614 | ||||
| with customers | 817 | 43 | 0 | 860 | |
| Liabilities under investment contracts | 0 | O | 11 979 | 0 | 11 979 |
| Derivatives | 0 | 6 305 | 0 | 1 364 | 7 669 |
| Short positions | 0 | 1 093 | 0 | 0 | 1 093 |
| In equity instruments | 0 | 15 | 0 | 0 | 15 |
| In debt securities | 0 | 1 078 | 0 | 0 | 1 078 |
| Other | 3 003 | 1 | 0 | 0 | 3 004 |
| Total | 235 448 | 7 667 | 14 244 | 1 364 | 258 723 |
| FINANCIAL LIABILITIES, 31-12-2019 | |||||
| Deposits from credit institutions and investment firms (excl. | 18 731 | O | 0 | 0 | 18 731 |
| repos) | |||||
| of which repayable on demand | 4 669 | ||||
| Deposits from customers and debt securities (excl. repos) | 200 607 | 223 | 2 539 | 0 | 203 369 |
| Demand deposits | 85 626 | O | 0 | 0 | 85 626 |
| lime deposits | 15 271 | 39 | 184 | 0 | 15 494 |
| Savings accounts | 69 057 | 0 | 0 | 0 | 69 057 |
| Special deposits | 2 465 | 0 | 0 | 0 | 2 465 |
| Other deposits | 542 | 0 | 0 | 0 | 542 |
| Certificates of deposit | 10 538 | 0 | 8 | 0 | 10 546 |
| Savings certificates | 1 025 | 0 | 0 | 0 | 1 025 |
| Non-convertible bonds | 13 756 | 183 | 2 200 | 0 | 16 139 |
| Non-convertible subordinated liabilities | 2 327 | O | 147 | 0 | 2 474 |
| Repos | 2 565 | 0 | 0 | 0 | 2 565 |
| with credit institutions and investment firms | 2 262 | O | O | O | 2 262 |
| with customers | 302 | O | 0 | 0 | 303 |
| Liabilities under investment contracts | O | O | 13 610 | O | 13 610 |
| Derivatives | 0 | 5 057 | 0 | 1 171 | 6 227 |
| Short positions | 0 | 1 708 | 0 | 0 | 1 708 |
| In equity instruments | 0 | 14 | 0 | 0 | 14 |
| 0 | 1 693 | 0 | 0 | ||
| In debt securities Other |
1 693 | ||||
| 2 190 | O | 0 | 0 | 2 190 | |
| Total | 224 093 | 6 988 | 16 149 | 1 171 | 248 400 |
| 31-03-2020 | 31-12-2019 | |||||
|---|---|---|---|---|---|---|
| Carrying | Carrying | Carrying | Carrying | |||
| (in millions of EUR) | value before | value after | value before | value after | ||
| impairment | Impairment | impairment | impairment | Impairment | impairment | |
| FINANCIAL ASSETS AT AMORTISED COST | ||||||
| Loans and advances (*) | 196 638 | - 2 851 | 193 787 | 189 446 | - 2 855 | 186 592 |
| Stage 1 (12-month ECL) | 173 214 | - 132 | 173 082 | 165 326 | - 131 | 165 195 |
| Stage 2 (lifetime ECL) | 18 075 | 299 | 17 775 | 18 558 | 254 | 18 304 |
| Stage 3 (lifetime ECL) | 5 174 | - 2 398 | 2777 | 5 381 | - 2 444 | 2 937 |
| Purchased or originated credit impaired assets (POCI) |
175 | 22 | 153 | 182 | - 26 | 155 |
| Debt Securities | 43 880 | 12 | 43 868 | 43 010 | - 12 | 42 998 |
| Stage 1 (12-month ECL) | 43 786 | 5 | 43 781 | 42 934 | 5 - |
42 930 |
| Stage 2 (lifetime ECL) | 87 | 2 | 85 | દિવે | 2 - |
67 |
| Stage 3 (lifetime ECL) | 7 | 6 | 2 | 7 | 6 - |
1 |
| Purchased or originated credit impaired assets (POCI) |
0 | 0 | 0 | 0 | 0 | 0 |
| FINANCIAL ASSETS AT FAIR VALUE THROUGH OC | ||||||
| Debt Securities | 18 183 | - 6 | 18 178 | 18 793 | 5 - |
18 788 |
| Stage 1 (12-month ECL) | 18 033 | 4 | 18 029 | 18 771 | ব - |
18 767 |
| Stage 2 (lifetime ECL) | 151 | 2 | 149 | 22 | 1 - |
22 |
| Stage 3 (lifetime ECL) | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 | 0 | 0 | 0 |
Impairments on financial assets are rather stable with business as usual and Covid-19 related charges being compensated by accounting write-offs and FX-effects.
For more details on how KBC defines and determines (i) fair value and the fair value hierarchy and (ii) level 3 valuations reference is made to notes 4.4 up to and including 4.7 of the annual accounts 2019.
| (in millions of EUR) | 31-03-2020 | 31-12-2019 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Fair value hierarchy | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |
| FINANCIAL ASSETS AT FAIR VALUE | |||||||||
| Mandatorily measured at fair value through profit or loss (other than held for trading) |
13 757 | 419 | 340 | 14 516 | 15 536 | 441 | 320 | 16 298 | |
| Held for trading | 3 413 | 7 067 | 1 094 | 11 574 | 1 685 | 4 381 | 1 200 | 7 266 | |
| Fair value option | 0 | 0 | 0 | 0 | 0 | ||||
| At fair value through OCI | 14 403 | 3 462 | 562 | 18 427 | 14 945 | 3 630 | 463 | 19 037 | |
| Hedging derivatives | 0 | 178 | 0 | 178 | 0 | 158 | 0 | 158 | |
| Total | 31 574 | 11 126 | 1 996 | 44 696 | 32 166 | 8 611 | 1 982 | 42 759 | |
| FINANCIAL LIABILITIES AT FAIR VALUE | |||||||||
| Held for trading | 059 | 5 417 | 1 290 | 7 667 | 1 708 | 3 259 | 2 021 | 6 988 | |
| Designated at fair value | 11 979 | 597 | 1 668 | 14 244 | 13 610 | 657 | 1 883 | 16 149 | |
| Hedging derivatives | 0 | 1 364 | 0 | 1 364 | O | 1 171 | O | 1 171 | |
| Total | 12 938 | 7 379 | 2 958 | 23 274 | 15 317 | 5 087 | 3 903 | 24 308 |
During 1Q 2020, KBC transferred about 135 million euros' worth of financial assets and liabilities out of level 1 and into level 2. It also reclassified approximately 192 million euros' worth of financial assets and liabilities from level 2 to level 1. Most of these reclassifications were carried out due to a change in the liquidity of government and corporate bonds.
In 1Q 2020 significant movements in financial assets and liabilities classified in level 3 of the fair value hierarchy included the following:
| Quantities | 31-03-2020 | 31-12-2019 |
|---|---|---|
| Ordinary shares | 416 394 642 | 416 394 642 |
| of which ordinary shares that entitle the holder to a dividend payment | 416 394 642 | 416 394 642 |
| of which treasury shares | 28 373 | 38 607 |
| Additional information | ||
| Par value per share (in EUR) | 3.51 | 3.51 |
| Number of shares issued but not fully paid up | O | O |
The ordinary shares of KBC Group NV have no nominal value and are quoted on NYSE Euronext (Brussels).
The treasury shares almost fully relate to positions in shares of KBC Group to hedge outstanding equity derivatives.
In 1Q 2020 : none
On 31 May 2019, ČSOB has acquired the remaining 45% stake in ČMSS from Bausparkasse Schwäbisch Hall (BSH) for a total consideration of 240 million euros. As a result, ČMSS is as of 1 June 2019 fully consolidated (previously equity method).
Significant non-adjusting events between the balance sheet date (31 March 2020) and the publication of this report (14 May 2020):
During April 2020 governments and regulators have taken various further measures to address the impacts of the Covid-19 pandemic on the economy. Besides several measures in economic, social and employment areas, legal regulations requiring banks to offer payment moratoria for the repayment of loans to their retail and corporate clients have been adopted in almost all jurisdictions where KBC Group operates.
The P&L impact of all payment moratoria is not known yet, as this e.g. will depend on the number of customers who will make use of them. Other guarantee schemes and liquidity measures have been announced or have been concretized also after 31 March 2020. The Covid-19 pandemic and the consequences for the economy as well as the measures taken by governments and regulators will affect KBC Group's financial performance going forward, including potentially significant impact on credit losses, as well as impact on total income. Given the large uncertainty amongst others on the length and depth of the economic downturn, the significant number of government measures in each of our core countries, some of which still need to be worked out in detail, and the unknown amount of customers which will call upon these mitigating measures, making an estimate for the expected credit losses is extremely difficult. We will continue to monitor this closely and evaluate it further in the following quarters. We refer to note 1.4 for further details.




The main source of credit risk is the loan portfolio of the bank. A snapshot of the banking portfolio is shown in the table below. It includes all payment credit, guarantee credit and standby credit granted by KBC to private persons, companies, governments and banks. Bonds held in the investment portfolio are included if they are corporate- or bank-issued, hence government bonds and trading book exposure are not included. Further on in this chapter, extensive information is provided on the credit portfolio of each business unit. Information specifically on sovereign bonds can be found under 'How do we manage our risks (in the annual accounts 2019)'.
| Credit risk: loan portfolio overview | ||
|---|---|---|
| Total loan portfolio (in billions of EUR) | 31-03-2020 | 31-12-2019 |
| Portfolio outstanding + undrawn 1 | 220 | 218 |
| Portfolio outstanding 1 | ||
| 180 | 175 | |
| Total loan portfolio, by business unit (as a % of the portfolio of credit outstanding) | ||
| Belgium | 66% | 64% |
| Czech Republic | 17% | 18% |
| International Markets | 15% | 16% |
| Group Centre | 2% | 2% |
| Total | 100% | 100% |
| Total outstanding loan portfolio sector breakdown | ||
| Private persons Finance and insurance |
40.1% | 41.7% |
| Authorities | 9.2% | 7.6% |
| Corporates | 3.7% | 2.9% |
| services | 47.0% | 47.7% |
| distribution | 10.7% | 10.9% |
| real estate | 7.0% | 7.3% |
| building & construction | 6.3% 3.8% |
6.4% 3.9% |
| agriculture, farming, fishing | 2.6% | 2.7% |
| automotive | 2.6% | 2.6% |
| food producers | 1.7% | 1.7% |
| electricity | 1.6% | 1.6% |
| metals | 1.5% | 1.4% |
| chemicals | 1.4% | 1.3% |
| machinery & heavy equipment shipping |
1.0% | 1.0% |
| hotels, bars & restaurants | 0.9% | 0.8% |
| traders | 0.7% | 0.7% |
| oil, gas & other fuels | 0.6% | 0.6% |
| textile & apparel | 0.6% | 0.6% |
| electrotechnics | 0.6% | 0.6% |
| other 2 | 0.6% 2.9% |
0.5% 3.1% |
| Total outstanding loan portfolio geographical breakdown | ||
| Home countries | 85.1% | 86.4% |
| Belgium | 52.7% | 52.9% |
| Czech Republic | 16.8% | 17.6% |
| Ireland | 5.7% | 5.9% |
| Slovakia Hungary |
4.8% 3.0% |
4.9% 3.1% |
| Bulgaria | 2.0% | 2.0% |
| Rest of Western Europe | 9.7% | 8.6% |
| France | 3.3% | 2.7% |
| Netherlands | 1.6% | 1.6% |
| Great Britain | 1.2% | 1.1% |
| Spain | 0.4% | 0.4% |
| Luxemburg | 0.9% | 0.8% |
| Germany | 0.8% | 0.8% |
| other | 1.6% | 1.2% |
| Rest of Central Europe | 0.4% | 0.4% |
| Russia | 0.1% | 0.1% |
| other | 0.3% | 0.3% |
| North America | 1.7% | 1.5% |
| USA | 1.1% | 1.0% |
| Canada | 0.5% | 0.5% |
| Asia | 1.6% | 1.5% |
| China Hong Kong |
1.0% 0.2% |
0.9% 0.2% |
| Singapore | 0.1% | 0.1% |
| other | 0.3% | 0.3% |
| Rest of the world | 1.6% | 1.6% |
| 31-03-2020 | 31-12-2019 | |
|---|---|---|
| Loan portfolio by counterparty (part of portfolio, as % of the portfolio of credit outstanding) | ||
| Retail | 40% | 42% |
| of which: mortgages | 37% | 38% |
| of which: consumer finance | 3% | 3% |
| SME | 21% | 22% |
| Corporate | 39% | 37% |
| Loan portfolio by IFRS 9 ECL stage (part of portfolio, as % of the portfolio of credit outstanding) | ||
| Stage 1 (credit risk has not increased significantly since initial recognition) | 86% | 85% |
| of which: PD 1 - 4 | 64% | 63% |
| of which: PD 5 - 9 including unrated | 22% | 23% |
| Stage 2 (credit risk has increased significantly since initial recognition – not credit impaired) incl. POCI 3 | 11% | 11% |
| of which: PD 1 - 4 | 3% | 3% |
| of which: PD 5 - 9 including unrated | 8% | 8% |
| Stage 3 (credit risk has increased significantly since initial recognition – credit impaired) incl. POCI 3 | 3% | 4% |
| of which: PD 10 impaired loans | 1% | 2% |
| of which: more than 90 days past due (PD 11+12) | 2% | 2% |
| Impaired loans (in millions of EUR or %) | ||
| Amount outstanding | 5 921 | 6 160 |
| of which: more than 90 days past due | 3 378 | 3 401 |
| Ratio of impaired loans, per business unit | ||
| Belgium | 2.2% | 2.4% |
| Czech Republic | 2.2% | 2.3% |
| International Markets | 8.2% | 8.5% |
| Group Centre | 12.6% | 12.4% |
| Total | 3.3% | 3.5% |
| of which: more than 90 days past due | 1.9% | 1.9% |
| Stage 3 loan loss impairments (in millions of EUR) and Cover ratio (%) | ||
| Stage 3 loan loss impairments | 2 568 | 2 584 |
| of which: more than 90 days past due | 2 042 | 2 050 |
| Cover ratio of impaired loans | ||
| Stage 3 loan loss impairments / impaired loans | 43% | 42% |
| of which: more than 90 days past due | 60% | 60% |
| Cover ratio of impaired loans, mortgage loans excluded | ||
| Stage 3 loan loss impairments / impaired loans, mortgage loans excluded | 53% | 50% |
| of which: more than 90 days past due | 71% | 72% |
| Credit cost, by business unit (%) | ||
| Belgium | 0.40% | 0.22% |
| Czech Republic | 0.10% | 0.04% |
| International Markets | 0.08% | -0.07% |
| Slovakia | 0.30% | 0.14% |
| Hungary | -0.12% | -0.02% |
| Bulgaria | 0.31% | 0.14% |
| Ireland | -0.06% | -0.32% |
| Group Centre | -1.07% | -0.88% |
| Total | 0.27% | 0.12% |
1 Outstanding portfolio includes all on-balance sheet commitments and off-balance sheet guarantees but excludes off-balance sheet undrawn commitments; the amounts are measured in Gross Carrying Amounts;
2 Other includes corporate sectors not exceeding 0.5% concentration and unidentified sectors 3 Purchased or originated credit impaired assets
Impaired loans are loans for which full (re)payment of the contractual cash flows is deemed unlikely. This coincides with KBC's Probability-of-Default-classes 10, 11 and 12 (see annual accounts FY 2019 - section on credit risk for more information on PD classification). These impaired loans are equal to 'non-performing loans' under the definition used by EBA.
Since 1Q18 a switch has been made in the reported 'outstanding' figures from drawn principal to the new IFRS 9 definition of gross carrying amount (GCA), i.e. including reserved and accrued interests. The additional inclusion of reserved interests led, among others, to an increase in the reported amount of impaired loans. Furthermore, the transaction scope of the credit portfolio was extended and now additionally includes the following 4 elements: (1) bank exposure (money market placements, documentary credit, accounts), (2) debtor risk KBC Commercial Finance, (3) unauthorized overdrafts, and (4) reverse repo (excl. central bank exposure).
| 31-03-2020, in millions of EUR | Belgium 1 | Foreign branches | Total Business Unit Belgium | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total portfolio outstanding | 109 928 | 8 473 | 118 400 | |||||||
| Counterparty break down | % outst. | % outst. | % outst. | |||||||
| SME / corporate | 41 801 | 38,0% | 8 473 | 100,0% | 50 274 | 42,5% | ||||
| retail | 68 126 | 62,0% | 0 | 0,0% | 68 126 | 57,5% | ||||
| o/w private | 37 035 | 33,7% | 0 | 0,0% | 37 035 | 31,3% | ||||
| o/w companies | 31 092 | 28,3% | 0 | 0,0% | 31 092 | 26,3% | ||||
| Mortgage loans | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | |||||
| total | 35 346 | 32,2% | 56% | 0 | 0,0% | - | 35 346 | 29,9% | ||
| o/w FX mortgages | 0 | 0,0% | - | 0 | 0,0% | - | 0 | 0,0% | ||
| o/w ind. LTV > 100% | 580 | 0,5% | - | 0 | 0,0% | - | 580 | 0,5% | ||
| Probability of default (PD) | % outst. | % outst. | % outst. | |||||||
| low risk (PD 1-4; 0.00%-0.80%) | 84 927 | 77,3% | 5 023 | 59,3% | 89 950 | 76,0% | ||||
| medium risk (PD 5-7; 0.80%-6.40%) | 19 053 | 17,3% | 3 152 | 37,2% | 22 205 | 18,8% | ||||
| high risk (PD 8-9; 6.40%-100.00%) | 3 224 | 2,9% | 125 | 1,5% | 3 349 | 2,8% | ||||
| impaired loans (PD 10 - 12) | 2 439 | 2,2% | 170 | 2,0% | 2 609 | 2,2% | ||||
| unrated | 285 | 0,3% | 3 | 0,0% | 288 | 0,2% | ||||
| Overall risk indicators | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | ||||
| outstanding impaired loans | 2 439 | 1 056 | 43,3% | 170 | 116 | 68,3% | 2 609 | 1 172 | 44,9% | |
| o/w PD 10 impaired loans | 1 210 | 299 | 24,7% | 76 | 46 | 60,1% | 1 287 | 345 | 26,8% | |
| o/w more than 90 days past due (PD 11+12) | 1 229 | 757 | 61,6% | 94 | 70 | 75,0% | 1 323 | 827 | 62,6% | |
| all impairments (stage 1+2+3) | 1 285 | 133 | 1 418 | |||||||
| o/w stage 1+2 impairments (incl. POCI) | 229 | 17 | 246 | |||||||
| o/w stage 3 impairments (incl. POCI) | 1 056 | 116 | 1 172 | |||||||
| 2019 Credit cost ratio (CCR) | 0,20% | 0,41% | 0,22% | |||||||
| YTD 2020 CCR | 0,42% | 0,14% | 0,40% |
1 Belgium = KBC Bank (all retail and corporate credit lending activities except for the foreign branches, part of non-legacy portfolio assigned to BU Belgium), CBC, KBC Lease Belgium, KBC Immolease and KBC Commercial Finance
, part
| Total portfolio outstanding | 30 666 | ||
|---|---|---|---|
| Counterparty break down | % outst. | ||
| SME / corporate | 8 661 | 28.2% | |
| retail | 22 006 | 71.8% | |
| o/w private | 17 355 | 56.6% | |
| o/w companies | 4 651 | 15.2% | |
| Mortgage loans | % outst. | ind. LTV | |
| total | 15 201 | 49.6% | 61% |
| o/w FX mortgages | 0 | 0.0% | - |
| o/w ind. LTV > 100% | 209 | 0.7% | - |
| Probability of default (PD) | % outst. | ||
| low risk (PD 1-4; 0.00%-0.80%) | 17 700 | 57.7% | |
| medium risk (PD 5-7; 0.80%-6.40%) | 11 116 | 36.2% | |
| high risk (PD 8-9; 6.40%-100.00%) | 1 170 | 3.8% | |
| impaired loans (PD 10 - 12) | 666 | 2.2% | |
| unrated | 13 | 0.0% | |
| Overall risk indicators 1 | stage 3 imp. | % cover | |
| outstanding impaired loans | 666 | 315 | 47.2% |
| o/w PD 10 impaired loans | 307 | 74 | 24.2% |
| o/w more than 90 days past due (PD 11+12) | 360 | 241 | 66.9% |
| all impairments (stage 1+2+3) | 421 | ||
| o/w stage 1+2 impairments (incl. POCI) | 106 | ||
| o/w stage 3 impairments (incl. POCI) | 315 | ||
| 2019 Credit cost ratio (CCR) | 0.04% | ||
| YTD 2020 CCR | 0.10% |
1 CCR at country level in local currency
| Loan portfolio Business Unit International Markets | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31-03-2020, in millions of EUR | Ireland | Slovakia | Hungary | Bulgaria | Total Int Markets | ||||||||||
| Total portfolio outstanding | 10 088 | 8 329 | 5 381 | 3 584 | 27 383 | ||||||||||
| Counterparty break down | % outst. | % outst. | % outst. | % outst. | % outst. | ||||||||||
| SME / corporate | 25 | 0.2% | 3 078 | 37.0% | 3 323 | 61.7% | 1 193 | 33.3% | 7 618 | 27.8% | |||||
| retail | 10 063 | 99.8% | 5 251 | 63.0% | 2 058 | 38.3% | 2 392 | 66.7% | 19 764 | 72.2% | |||||
| o/w private | 10 026 | 99.4% | 4 277 | 51.3% | 1 908 | 35.5% | 1 375 | 38.4% | 17 586 | 64.2% | |||||
| o/w companies | 37 | 0.4% | 974 | 11.7% | 150 | 2.8% | 1 016 | 28.4% | 2 178 | 8.0% | |||||
| Mortgage loans | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ||||||
| total | 9 959 | 98.7% | 66% | 3 778 | 45.4% | 67% | 1 513 | 28.1% | 67% | 729 | 20.3% | 65% | 15 978 | 58.4% | |
| o/w FX mortgages | 0 | 0.0% | - | 0 | 0.0% | - | 4 | 0.1% | 83% | 86 | 2.4% | 67% | 90 | 0.3% | |
| o/w ind. LTV > 100% | 689 | 6.8% | - | 35 | 0.4% | - | 86 | 1.6% | - | 32 | 0.9% | - | 842 | 3.1% | |
| Probability of default (PD) | % outst. | % outst. | % outst. | % outst. | % outst. | ||||||||||
| low risk (PD 1-4; 0.00%-0.80%) | 890 | 8.8% | 5 244 | 63.0% | 2 795 | 51.9% | 1 013 | 28.3% | 9 942 | 36.3% | |||||
| medium risk (PD 5-7; 0.80%-6.40%) | 6 783 | 67.2% | 2 319 | 27.8% | 2 244 | 41.7% | 1 917 | 53.5% | 13 263 | 48.4% | |||||
| high risk (PD 8-9; 6.40%-100.00%) | 831 | 8.2% | 596 | 7.2% | 205 | 3.8% | 290 | 8.1% | 1 921 | 7.0% | |||||
| impaired loans (PD 10 - 12) | 1 585 | 15.7% | 149 | 1.8% | 136 | 2.5% | 364 | 10.1% | 2 234 | 8.2% | |||||
| unrated | 0 | 0.0% | 21 | 0.2% | 1 | 0.0% | 0 | 0.0% | 22 | 0.1% | |||||
| Overall risk indicators 1 | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | |||||
| outstanding impaired loans | 1 585 | 387 | 24.4% | 149 | 101 | 67.3% | 136 | 75 | 54.7% | 364 | 162 | 44.7% | 2 234 | 725 | 32.4% |
| o/w PD 10 impaired loans | 770 | 68 | 8.8% | 20 | 7 | 36.0% | 37 | 12 | 31.4% | 66 | 8 | 12.8% | 894 | 95 | 10.6% |
| o/w more than 90 days past due (PD 11+12) | 815 | 319 | 39.2% | 129 | 93 | 72.2% | 99 | 63 | 63.4% | 297 | 154 | 51.8% | 1 341 | 630 | 47.0% |
| all impairments (stage 1+2+3) | 403 | 150 | 95 | 186 | 833 | ||||||||||
| o/w stage 1+2 impairments (incl. POCI) | 16 | 49 | 21 | 23 | 109 | ||||||||||
| o/w stage 3 impairments (incl. POCI) | 387 | 101 | 75 | 162 | 725 | ||||||||||
| 2019 Credit cost ratio (CCR) | -0.32% | 0.14% | -0.02% | 0.14% | -0.07% | ||||||||||
| YTD 2020 CCR | -0.06% | 0.30% | -0.12% | 0.31% | 0.08% |
1 CCR at country level in local currency
| Total portfolio outstanding | 3 253 | ||
|---|---|---|---|
| Counterparty break down | % outst. | ||
| SME / corporate | 3 253 | 100,0% | |
| retail | 0 | 0,0% | |
| o/w private | 0 | 0,0% | |
| o/w companies | 0 | 0,0% | |
| Mortgage loans | % outst. | ind. LTV | |
| total | 0 | 0,0% | - |
| o/w FX mortgages | 0 | 0,0% | - |
| o/w ind. LTV > 100% | 0 | 0,0% | - |
| Probability of default (PD) | % outst. | ||
| low risk (PD 1-4; 0.00%-0.80%) | 2 641 | 81,2% | |
| medium risk (PD 5-7; 0.80%-6.40%) | 156 | 4,8% | |
| high risk (PD 8-9; 6.40%-100.00%) | 44 | 1,4% | |
| impaired loans (PD 10 - 12) | 411 | 12,6% | |
| unrated | 0 | 0,0% | |
| Overall risk indicators | stage 3 imp. | % cover | |
| outstanding impaired loans | 411 | 356 | 86,7% |
| o/w PD 10 impaired loans | 56 | 12 | 22,3% |
| o/w more than 90 days past due (PD 11+12) | 355 | 344 | 96,8% |
| all impairments (stage 1+2+3) | 361 | ||
| o/w stage 1+2 impairments (incl. POCI) | 4 | ||
| o/w stage 3 impairments (incl. POCI) | 356 | ||
| 2019 Credit cost ratio (CCR) | -0,88% | ||
| YTD 2020 CCR | -1,07% |
1 Total Group Centre = part of non-legacy portfolio assigned to BU Group and activities in wind-down (e.g. ex-Antwerp Diamond Bank)
KBC reports its solvency at group, banking and insurance level, calculating it on the basis of IFRS figures and the relevant guidelines issued by the competent regulator.
We report the solvency of the group, the bank and the insurance company based on IFRS data and according to the rules imposed by the regulator. For the KBC group, this implies that we calculate our solvency ratios based on CRR/CRD IV. This regulation entered gradually into force on 1 January 2014. The general rule under CRR/CRD IV for insurance participations is that an insurance participation is deducted from common equity at group level, unless the competent authority grants permission to apply a risk weighting instead (Danish compromise). KBC received such permission from the supervisory authority and hence reports its solvency on the basis of a 370% risk weighting being applied to the holdings of own fund instruments of the insurance company, after having deconsolidated KBC Insurance from the group figures.
In addition to the solvency ratios under CRD IV/CRR, KBC is considered a financial conglomerate since it covers both significant banking and insurance activities. Therefore KBC also has to disclose its solvency position as calculated in accordance with the Financial Conglomerate Directive (FICOD; 2002/87/EC. This implies that available capital is calculated on the basis of the consolidated position of the group and the eligible items recognised as such under the prevailing sectorial rules, which are CRR/CRD IV for the banking business and Solvency II for the insurance business. The capital requirement for the insurance business based on Solvency II is multiplied by 12.5 to obtain a risk weighted asset equivalent.
The Internal Rating Based (IRB) approach is since its implementation in 2008 the primary approach to calculate KBC's risk weighted assets. This is, based on a full application of all the CRD IV/CRR rules, used for approximately 92% of the weighted credit risks, of which approx. 88% according to Advanced and approx. 4% according to Foundation approach. The remaining weighted credit risks (ca. 8%) are calculated according to the Standardised approach.
The overall capital requirement (CET1) that KBC is to uphold is set at 10.55% (fully loaded, Danish Compromise which includes the CRR/CRD IV minimum requirement (4.5%), the Pillar 2 Requirement (1.75%) and the buffers set by national competent authorities (2.50% Capital Conservation Buffer, 1.50% Systemic Buffer and 0.30% Countercyclical Buffer). Furthermore ECB has set a Pillar 2 Guidance of 1.00%.
ECB temporarily allows banks to operate below the P2G and Capital Conservation Buffer and hence to use these buffers to withstand potential stress. This temporarily brings the regulatory minimum to 8.05% (being 10.55% – 2.5%). ECB does not have any discretion to waive the application of automatic restrictions to distributions (MDA) as they are set out in the CRR/CRD package. Therefore, the CCB remains included in the threshold for MDA).
(1) Fully in line with the European Central Bank recommendation that at least until 1 October 2020 no dividends are paid out and no irrevocable commitment to pay out dividends is udertaken by the credit institutions for the financial year 2019 and 2020 and that credit institutions refrain from share buy-backs aimed at remunerating shareholders, the KBC Board of Directors has communicated on 30 March 2020:
• to withdraw the proposal of the Annual Shareholders' meeting of 7 May 2020 to declare a final total (gross) dividend over 2019 profit of 2.5 EUR per share (after an interim dividend of 1 EUR per share was paid in November 2019 already)
• to evaluate in October 2020 wether all or part of the withdrawn final dividend should as yet be paid out later this year(2020) in the form of an interim dividend
• to cancel the proposed share buy-back program of 5.5 million shares
in deviation from what was announced in the press release of 13 February 2020 at the occasion of the 4th quarter 2019 results publication.
(2) In line with the ECB recommendation we intend to apply (subject to approval) the IFRS 9 transitional measures going forward.
Distributions (being dividend payments, payments related to additional tier 1 instruments or variable remuneration) are limited in case the combined buffer requirements described above are breached. This limitation is also referred to as "Maximum Distributable Amount" or "MDA" thresholds.
The table below provides an overview of the buffers KBC Group has compared to these thresholds, both on an actuals basis (i.e. versus the regulatory targets that apply at the reporting date) and a fully loaded basis (i.e. versus the regulatory targets that will apply going forward).
| Buffer vs. Overall Capital Requirement (in millions of EUR) | 31/03/2020 | 31/12/2019 | ||
|---|---|---|---|---|
| (consolidated; under CRR/CRD IV, Danish compromise method) | Fully loaded | Actuals | Fully loaded | Actuals |
| CET1 Pillar 1 minimum | 4,50% | 4,50% | 4,50% | 4,50% |
| Pillar 2 requirement | 1,75% | 1,75% | 1,75% | 1,75% |
| Capital conservation buffer | 2,50% | 2,50% | 2,50% | 2,50% |
| Buffer for systemically important institutions (O-SII) | 1,50% | 1,50% | 1,50% | 1,50% |
| Entity-specific countercyclical buffer | 0,30% | 0,46% | 0,30% | 0,43% |
| Overall Capital Requirement (OCR) | 10,55% | 10,71% | 10,55% | 10,68% |
| CET1 used to satisfy shortfall in AT1 bucket | 0,04% | 0,04% | 0,00% | 0,00% |
| CET1 used to satisfy shortfall in T2 bucket | 0,10% | 0,10% | 0,05% | 0,05% |
| CET1 requirement | 10,69% | 10,85% | 10,60% | 10,74% |
| CET1 capital | 16 729 | 16 729 | 16 989 | 16 989 |
| CET1 buffer (= buffer to MDA) | 5 782 | 5 615 | 6 486 | 6 353 |
Following table groups the solvency on the level of KBC Group according to different methodologies and calculation methods, including the deduction method.
| Overview of KBC Group's capital ratios (in millions of EUR) 31-03-2020 |
numerator equity) |
denominator (total (common weighted risk volume) |
ratio (%) | |
|---|---|---|---|---|
| CRDIV, Common Equity ratio | ||||
| Danish Compromise | Fully loaded | 16 729 | 102 425 | 16.33% |
| Deduction Method | Fully loaded | 15 938 | 97 485 | 16.35% |
| Financial Conglomerates Directive | Fully loaded | 17 132 | 112 317 | 15.25% |
KBC's CET1 ratio of 16.3% at end 1Q20 represents a solid capital buffer:
| In millions of EUR Fully loaded Fully loaded Total regulatory capital (after profit appropriation) 20 172 20 414 Tier-1 capital 18 229 18 489 Common equity 16 729 16 989 Parent shareholders' equity (after deconsolidating KBC Insurance) 17 640 17 933 Intangible fixed assets (incl deferred tax impact) (-) - 721 - 726 Goodwill on consolidation (incl deferred tax impact) (-) - 720 - 766 Minority interests O 0 Hedging reserve (cash flow hedges) (-) 1 355 1 331 Valuation diff. in fin. liabilities at fair value - own credit risk (-) - 30 - 9 Value adjustment due to the requirements for prudent valuation (-) - 132 - 54 Dividend payout (-) 0 O Renumeration of AT1 instruments (-) - 15 - 11 Deduction re. financing provided to shareholders (-) - 57 - 57 Deduction re. Irrevocable payment commitments (-) - 45 - 45 IRB provision shortfall (-) - 110 - 140 Deferred tax assets on losses carried forward (-) - 437 - 467 Limit on deferred tax assets from timing differences relying on future profitability and significant O 0 participations in financial sector entities (-) Additional going concern capital 1 500 1 500 CRR compliant AT1 instruments 1 500 1 500 Minority interests to be included in additional going concern capital 0 0 Tier 2 capital 1 943 1 925 IRB provision excess (+) 149 130 Subordinated liabilities 1 794 1 795 Subordinated loans non-consolidated financial sector entitles (-) O 0 Minority interests to be included in tier 2 capital O 0 Total weighted risk volume 102 425 99 071 Banking 89 838 92 907 Insurance 9 133 9 133 Holding activities 398 124 Elimination of intercompany transactions - 14 - 25 Solvency ratios Common equity ratio 17.15% 16.33% Tier-1 ratio 17.80% 18.66% Total capital ratio 19.69% 20.61% |
31-03-2020 | 31-12-2019 |
|---|---|---|
At 31 March 2020, our fully loaded common equity ratio (Basel III, under the Danish compromise) amounted to 16.3%, compared to 17.1% at the end of 2019. The 0.8 percentage point decrease was mainly Corona-related (0.5 percentage points).
| Leverage ratio KBC Group (Basel III fully loaded) In millions of EUR |
31-03-2020 | 31-12-2019 |
|---|---|---|
| Tier-1 capital (Danish compromise) | 18 229 | 18 489 |
| Total exposures | 281 748 | 273 029 |
| Total Assets | 301 451 | 290 735 |
| Deconsolidation KBC Insurance | -31 417 | -33 243 |
| Adjustment for derivatives | -6 453 | -2 882 |
| Adjustment for regulatory corrections in determining Basel III Tier-1 capital | -2 221 | -2 254 |
| Adjustment for securities financing transaction exposures | 1 133 | 638 |
| Off-balance sheet exposures | 19 255 | 20 035 |
| Leverage ratio | 6.47% | 6.77% |
As is the case for the KBC group, the solvency of KBC Bank is calculated based on CRR/CRD IV. The solvency of KBC Insurance is calculated on the basis of Solvency II rules as they became effective on 1 January 2016. The tables below show the tier-1 and CAD ratios calculated under Basel III (CRD IV/CRR) for KBC Bank, as well as the solvency ratio of KBC Insurance under Solvency II.
| KBC Bank consolidated - CRDIV/CRR (in millions of EUR) |
31-03-2020 | 31-12-2019 |
|---|---|---|
| Total regulatory capital, after profit appropriation | 16 370 | 16 660 |
| Tier-1 capital | 14 400 | 14 704 |
| Of which common equity | 12 900 | 13 204 |
| Tier-2 capital | 1 969 | 1 957 |
| Total weighted risks | 92 907 | 89 838 |
| Credit risk | 78 467 | 75 786 |
| Market risk | 3 100 | 2 713 |
| Operational risk | 11 340 | 11 340 |
| Solvency ratios | ||
| Common equity ratio | 13.9% | 14.7% |
| Tier-1 ratio | 15.5% | 16.4% |
| CAD ratio | 17.6% | 18.5% |
| Solvency II, KBC Insurance consolidated | 31-03-2020 | 31-12-2019 |
|---|---|---|
| (in millions of EUR) | ||
| Own Funds | 3 221 | 3 496 |
| Tier 1 | 2 721 | 2 996 |
| IFRS Parent shareholders equity | 3 055 | 3 422 |
| Dividend payout | - 156 | - 156 |
| Deduction intangible assets and goodwill (after tax) | - 128 | - 128 |
| Valuation differences (after tax) | - 579 | - 196 |
| Volatility adjustment | 574 | 104 |
| Other | - 44 | - 49 |
| Tier 2 | 500 | 500 |
| Subordinated liabilities | 500 | 500 |
| Solvency Capital Requirement (SCR) | 1 522 | 1 727 |
| Market risk | 1 100 | 1 389 |
| Non-life | 559 | 579 |
| Life | 679 | 689 |
| Health | 256 | 264 |
| Counterparty | 127 | 114 |
| Diversification | - 940 | - 991 |
| Other | - 260 | - 316 |
| Solvency II ratio | 212% | 202% |
Besides the ECB and NBB, which supervise KBC on a going concern basis, KBC is also subject to requirements set by the Single Resolution Board (SRB). The SRB is developing resolution plans for the major banks in the euro area. The resolution plan for KBC is based on a Single Point of Entry (SPE) approach at the level of KBC Group with 'bail-in' as the primary resolution tool. MREL measures the amount of own funds and eligible liabilities that can be credibly and feasibly bailed-in.
The Eligible instruments to satisfy the MREL target are defined in the '2018 SRB Policy for the 2nd wave of resolution plans' published on 16th January 2019. The so-called 'consolidated approach' (instruments issued by any entity within the resolution group were accepted by SRB to satisfy the MREL target) is replaced by a more restrictive 'hybrid approach'. This approach excludes MREL eligible liabilities that have not been issued by KBC Group NV (insofar as they do not constitute own funds) and requires tier-2 capital down-streamed by KBC Group NV to KBC Insurance to be deducted from MREL (in line with the treatment under CRR/CRD). At year-end 2019, 1 billion euro of instruments are no longer eligible for SRB to satisfy the MREL.
At the end of March 2020, the MREL ratio based on instruments issued by KBC Group NV following the 'hybrid approach' stands at 10.0% of TLOF. The latter is above the SRB requirement for KBC to achieve 9.67% as % of TLOF by year-end 2021.
Details on our segments or business units are available in the company presentation
| Business Unit Belgium | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2020 | FY 2019 | 4Q 2019 | 3Q 2019 | 2Q 2019 | 1Q 2019 |
| Breakdown P&L | ||||||
| Net interest income | 640 | 2 516 | 634 | 637 | 621 | 625 |
| Non-life insurance before reinsurance | 112 | 494 | 160 | 129 | 111 | 94 |
| Earned premiums Non-life | 283 | 1 115 | 285 | 284 | 275 | 270 |
| Technical charges Non-life | -172 | -621 | -125 | -156 | -165 | -175 |
| Life insurance before reinsurance | -21 | -95 | -21 | -25 | -24 | -25 |
| Earned premiums Life | 216 | 1 000 | 282 | 217 | 233 | 268 |
| Technical charges Life | -237 | -1 095 | -303 | -242 | -256 | -293 |
| Ceded reinsurance result | -9 | -2 | -10 | -5 | 4 | 8 |
| Dividend income | 11 | 78 | 15 | 14 | 38 | 11 |
| Net result from financial instruments at fair value through profit or loss | -217 | 177 | 89 | -9 | 43 | 54 |
| Net realised result from debt instr FV through OCI | 0 | 4 | 0 | 4 | 0 | 0 |
| Net fee and commission income | 308 | 1 182 | 307 | 297 | 293 | 286 |
| Net other income | 35 | 187 | 41 | 51 | 50 | 45 |
| TOTAL INCOME | 858 | 4 542 | 1 216 | 1 092 | 1 135 | 1 099 |
| Operating expenses | -828 | -2 485 | -550 | -552 | -575 | -807 |
| Impairment | -117 | -244 | -109 | -21 | -31 | -83 |
| On financial assets at amortised cost and at FV through OCI On other |
-116 0 |
-241 -4 |
-107 -2 |
-21 0 |
-30 -1 |
-82 -1 |
| Share in results of associated companies and joint ventures | -3 | -6 | -2 | -2 | -2 | -1 |
| RESULT BEFORE TAX | -90 | 1 807 | 556 | 517 | 526 | 208 |
| Income tax expense | 4 | -463 | -145 | -149 | -138 | -32 |
| RESULT AFTER TAX | -86 | 1 344 | 412 | 368 | 388 | 176 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | -86 | 1 344 | 412 | 368 | 388 | 176 |
| Banking | -55 | 979 | 301 | 287 | 289 | 102 |
| Insurance | -30 | 364 | 111 | 81 | 99 | 74 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 104 969 | 100 909 | 100 909 | 100 945 | 101 125 | 100 686 |
| of which Mortgage loans (end of period) | 36 489 | 36 445 | 36 445 | 35 832 | 35 674 | 35 234 |
| Customer deposits and debt certificates excl. repos (end of period) | 138 045 | 130 771 | 130 771 | 134 355 | 128 544 | 134 382 |
| Technical provisions plus unit-linked, life insurance | ||||||
| Interest Guaranteed (end of period) | 13 074 | 13 130 | 13 130 | 13 097 | 13 144 | 13 141 |
| Unit-Linked (end of period) Performance Indicators |
12 064 | 13 426 | 13 426 | 13 281 | 13 201 | 13 156 |
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 54 098 | 49 486 | 49 486 | 49 985 | 48 959 | 49 403 |
| Required capital, insurance (end of period) | 1 296 | 1 497 | 1 497 | 1 572 | 1 508 | 1 506 |
| Allocated capital (end of period) | 7 003 | 6 792 | 6 792 | 6 920 | 6 747 | 6 792 |
| Return on allocated capital (ROAC) | -5% | 20% | 24% | 22% | 23% | 11% |
| Cost/income ratio, banking | 95% | 58% | 48% | 53% | 54% | 78% |
| Combined ratio, non-life insurance | 95% | 89% | 82% | 91% | 91% | 93% |
| Net interest margin, banking | 1,68% | 1,69% | 1,68% | 1,68% | 1,67% | 1,71% |
| Business Unit Czech Republic | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2020 | FY 2019 | 4Q 2019 | 3Q 2019 | 2Q 2019 | 1Q 2019 |
| Breakdown P&L | ||||||
| Net interest income | 351 | 1 277 | 338 | 329 | 308 | 302 |
| Non-life insurance before reinsurance | 31 | 115 | 30 | 29 | 27 | 29 |
| Earned premiums Non-life | 75 | 281 | 73 | 72 | 70 | 66 |
| Technical charges Non-life | -44 | -166 | -43 | -43 | -42 | -37 |
| Life insurance before reinsurance | 14 | 54 | 12 | 13 | 15 | 14 |
| Earned premiums Life | 52 | 228 | 58 | 53 | 61 | 56 |
| Technical charges Life | -39 | -174 | -45 | -40 | -46 | -42 |
| Ceded reinsurance result | 0 | -5 | 0 | 0 | -2 | -3 |
| Dividend income | 0 | 1 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | -125 | -85 | 8 | -56 | -34 | -3 |
| Net realised result from debt instr FV through OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Net fee and commission income | 55 | 254 | 59 | 70 | 67 | 58 |
| Net other income | 9 | 102 | 3 | 2 | 84 | 13 |
| TOTAL INCOME | 335 | 1 714 | 451 | 388 | 465 | 410 |
| Operating expenses Impairment |
-221 -9 |
-770 -17 |
-200 -3 |
-187 -9 |
-179 -7 |
-204 1 |
| On financial assets at amortised cost and at FV through OCI | -8 | -12 | -1 | -9 | -4 | 2 |
| On other | -1 | -4 | -1 | 0 | -3 | 0 |
| Share in results of associated companies and joint ventures | 0 | 8 | 0 | 0 | 4 | 4 |
| RESULT BEFORE TAX | 105 | 935 | 248 | 192 | 283 | 212 |
| Income tax expense | -17 | -146 | -43 | -33 | -35 | -35 |
| RESULT AFTER TAX | 88 | 789 | 205 | 159 | 248 | 177 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 88 | 789 | 205 | 159 | 248 | 177 |
| Banking | 75 | 743 | 194 | 147 | 237 | 164 |
| Insurance | 13 | 47 | 11 | 12 | 11 | 13 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 28 286 | 29 857 | 29 857 | 29 200 | 28 711 | 23 685 |
| of which Mortgage loans (end of period) | 14 876 | 15 768 | 15 768 | 15 267 | 15 267 | 11 375 |
| Customer deposits and debt certificates excl. repos (end of period) | 37 627 | 39 559 | 39 559 | 38 170 | 38 536 | 32 210 |
| Technical provisions plus unit-linked, life insurance | ||||||
| Interest Guaranteed (end of period) | 588 | 629 | 629 | 616 | 621 | 613 |
| Unit-Linked (end of period) | 655 | 727 | 727 | 700 | 698 | 689 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 15 349 | 15 005 | 15 005 | 14 916 | 14 670 | 14 334 |
| Required capital, insurance (end of period) | 126 | 121 | 121 | 121 | 124 | 125 |
| Allocated capital (end of period) | 1 745 | 1 726 | 1 726 | 1 717 | 1 694 | 1 659 |
| Return on allocated capital (ROAC) | 20% | 47% | 48% | 38% | 60% | 43% |
| Cost/income ratio, banking | 68% | 44% | 44% | 48% | 38% | 50% |
| Combined ratio, non-life insurance | 90% | 94% | 94% | 94% | 96% | 93% |
| Net interest margin, banking (*) | 2,98% | 3,04% | 2,90% | 2,93% | 3,18% | 3,25% |
(*) As of 3Q 2019, ČMSS is taken fully into account
| Business Unit International Markets | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2020 | FY 2019 | 4Q 2019 | 3Q 2019 | 2Q 2019 | 1Q 2019 |
| Breakdown P&L | ||||||
| Net interest income | 219 | 863 | 219 | 216 | 214 | 213 |
| Non-life insurance before reinsurance | 40 | 136 | 35 | 32 | 35 | 35 |
| Earned premiums Non-life | 82 | 315 | 80 | 80 | 78 | 77 |
| Technical charges Non-life | -43 | -179 | -45 | -48 | -43 | -42 |
| Life insurance before reinsurance | 8 | 36 | 11 | 7 | 10 | 9 |
| Earned premiums Life | 29 | 95 | 24 | 21 | 23 | 27 |
| Technical charges Life | -21 | -60 | -14 | -14 | -14 | -18 |
| Ceded reinsurance result | -3 | -8 | -1 | -2 | -3 | -2 |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | -5 | 48 | 23 | 5 | 10 | 10 |
| Net realised result from debt instr FV through OCI | 0 | 2 | 0 | 1 | 0 | 1 |
| Net fee and commission income | 69 | 301 | 78 | 77 | 77 | 68 |
| Net other income | 6 | -11 | 4 | -16 | -2 | 3 |
| TOTAL INCOME | 333 | 1 367 | 370 | 321 | 340 | 336 |
| Operating expenses | -268 | -932 | -248 | -212 | -212 | -260 |
| Impairment | -24 | 12 | 18 | -6 | -7 | 7 |
| On financial assets at amortised cost and at FV through OCI | -6 | 18 | 22 | -5 | -6 | 8 |
| On other | -18 | -6 | -4 | -1 | -1 | 0 |
| Share in results of associated companies and joint ventures | 0 | 5 | 1 | 1 | 1 | 1 |
| RESULT BEFORE TAX | 42 | 452 | 141 | 104 | 122 | 85 |
| Income tax expense | -7 | -73 | -22 | -19 | -18 | -15 |
| RESULT AFTER TAX | 35 | 379 | 119 | 85 | 104 | 70 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 35 | 379 | 119 | 85 | 104 | 70 |
| Banking | 19 | 329 | 107 | 75 | 91 | 56 |
| Insurance | 16 | 49 | 12 | 11 | 13 | 14 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 25 109 | 25 050 | 25 050 | 24 718 | 24 333 | 24 146 |
| of which Mortgage loans (end of period) | 15 536 | 15 584 | 15 584 | 15 357 | 15 178 | 14 955 |
| Customer deposits and debt certificates excl. repos (end of period) | 23 197 | 24 041 | 24 041 | 22 939 | 22 970 | 23 063 |
| Technical provisions plus unit-linked, life insurance | ||||||
| Interest Guaranteed (end of period) | 254 | 255 | 255 | 258 | 262 | 261 |
| Unit-Linked (end of period) | 373 | 432 | 432 | 414 | 420 | 417 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 21 507 | 20 892 | 20 892 | 21 068 | 21 019 | 21 004 |
| Required capital, insurance (end of period) | 123 | 124 | 124 | 123 | 117 | 114 |
| Allocated capital (end of period) | 2 391 | 2 359 | 2 359 | 2 377 | 2 366 | 2 361 |
| Return on allocated capital (ROAC) | 6% | 16% | 20% | 14% | 18% | 12% |
| Cost/income ratio, banking | 84% | 70% | 68% | 67% | 64% | 80% |
| Combined ratio, non-life insurance | 82% | 88% | 89% | 93% | 88% | 84% |
| Net interest margin, banking | 2,61% | 2,64% | 2,60% | 2,61% | 2,65% | 2,69% |
| Hungary | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2020 | FY 2019 | 4Q 2019 | 3Q 2019 | 2Q 2019 | 1Q 2019 |
| Breakdown P&L | ||||||
| Net interest income | 62 | 254 | 64 | 64 | 64 | 62 |
| Non-life insurance before reinsurance | 14 | 48 | 14 | 10 | 12 | 12 |
| Earned premiums Non-life | 39 | 145 | 37 | 36 | 35 | 37 |
| Technical charges Non-life | -25 | -97 | -22 | -26 | -24 | -26 |
| Life insurance before reinsurance | 1 | 8 | 2 | 2 | 2 | 2 |
| Earned premiums Life | 9 | 17 | 4 | 4 | 4 | 4 |
| Technical charges Life | -8 | -9 | -2 | -2 | -2 | -3 |
| Ceded reinsurance result | -1 | -2 | 0 | -1 | 0 | -1 |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 2 | 33 | 9 | 6 | 8 | 10 |
| Net realised result from debt instr FV through OCI | 0 | 1 | 0 | 1 | 0 | 0 |
| Net fee and commission income | 49 | 215 | 56 | 55 | 55 | 48 |
| Net other income | 2 | 2 | 0 | 0 | 0 | 1 |
| TOTAL INCOME | 130 | 558 | 146 | 137 | 142 | 133 |
| Operating expenses | -101 | -353 | -87 | -83 | -81 | -102 |
| Impairment | -16 | -1 | -3 | -1 | 3 | 0 |
| On financial assets at amortised cost and at FV through OCI | 2 | 1 | -2 | -1 | 3 | 0 |
| On other | -18 | -2 | -1 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures RESULT BEFORE TAX |
0 13 |
0 204 |
0 57 |
0 53 |
0 64 |
0 31 |
| Income tax expense | -4 | -31 | -7 | -8 | -9 | -6 |
| RESULT AFTER TAX | 10 | 173 | 50 | 45 | 55 | 25 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 10 | 173 | 50 | 45 | 55 | 25 |
| Banking | 2 | 156 | 44 | 41 | 50 | 21 |
| Insurance | 8 | 18 | 6 | 4 | 4 | 4 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 4 534 | 4 623 | 4 623 | 4 522 | 4 527 | 4 395 |
| of which Mortgage loans (end of period) | 1 467 | 1 596 | 1 596 | 1 558 | 1 602 | 1 581 |
| Customer deposits and debt certificates excl. repos (end of period) | 7 435 | 7 953 | 7 953 | 7 140 | 7 388 | 7 484 |
| Technical provisions plus unit-linked, life insurance | ||||||
| Interest Guaranteed (end of period) | 48 | 52 | 52 | 52 | 55 | 55 |
| Unit-Linked (end of period) | 243 | 291 | 291 | 280 | 285 | 284 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 6 555 | 6 415 | 6 415 | 6 480 | 6 320 | 6 826 |
| Required capital, insurance (end of period) | 44 | 48 | 48 | 47 | 43 | 43 |
| Allocated capital (end of period) | 735 | 735 | 735 | 740 | 719 | 773 |
| Return on allocated capital (ROAC) | 5% | 23% | 27% | 24% | 29% | 13% |
| Cost/income ratio, banking | 82% | 64% | 61% | 62% | 58% | 79% |
| Combined ratio, non-life insurance | 84% | 90% | 87% | 96% | 90% | 89% |
| Slovakia | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2020 | FY 2019 | 4Q 2019 | 3Q 2019 | 2Q 2019 | 1Q 2019 |
| Breakdown P&L | ||||||
| Net interest income | 50 | 204 | 51 | 51 | 50 | 52 |
| Non-life insurance before reinsurance | 7 | 28 | 7 | 7 | 7 | 7 |
| Earned premiums Non-life | 12 | 47 | 12 | 12 | 12 | 11 |
| Technical charges Non-life | -5 | -19 | -5 | -5 | -4 | -4 |
| Life insurance before reinsurance | 3 | 12 | 4 | 2 | 3 | 3 |
| Earned premiums Life | 9 | 43 | 12 | 10 | 10 | 11 |
| Technical charges Life | -7 | -30 | -7 | -7 | -7 | -8 |
| Ceded reinsurance result | 0 | -2 | -1 | 0 | -1 | 0 |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | -8 | 4 | 10 | -5 | -2 | 0 |
| Net realised result from debt instr FV through OCI | 0 | 1 | 0 | 0 | 0 | 1 |
| Net fee and commission income | 15 | 65 | 16 | 16 | 16 | 15 |
| Net other income | 3 | 9 | 4 | 2 | 1 | 2 |
| TOTAL INCOME | 70 | 322 | 93 | 74 | 75 | 80 |
| Operating expenses | -59 | -211 | -53 | -52 | -51 | -55 |
| Impairment | -6 | -11 | 6 | -6 | -8 | -3 |
| On financial assets at amortised cost and at FV through OCI | -6 | -11 | 5 | -6 | -8 | -3 |
| On other | 0 | 0 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 4 | 100 | 46 | 16 | 15 | 23 |
| Income tax expense RESULT AFTER TAX |
-1 4 |
-21 79 |
-8 38 |
-4 12 |
-4 11 |
-5 18 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 4 | 79 | 38 | 12 | 11 | 18 |
| Banking | 1 | 69 | 36 | 10 | 8 | 15 |
| Insurance | 3 | 10 | 2 | 2 | 3 | 3 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 7 607 | 7 506 | 7 506 | 7 471 | 7 316 | 7 177 |
| of which Mortgage loans (end of period) | 3 714 | 3 641 | 3 641 | 3 593 | 3 482 | 3 381 |
| Customer deposits and debt certificates excl. repos (end of period) | 6 287 | 6 480 | 6 480 | 6 438 | 6 236 | 6 270 |
| Technical provisions plus unit-linked, life insurance | ||||||
| Interest Guaranteed (end of period) | 114 | 114 | 114 | 114 | 115 | 114 |
| Unit-Linked (end of period) | 89 | 100 | 100 | 97 | 104 | 106 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 5 123 | 4 985 | 4 985 | 5 030 | 4 960 | 5 121 |
| Required capital, insurance (end of period) | 26 | 27 | 27 | 28 | 26 | 24 |
| Allocated capital (end of period) | 567 | 560 | 560 | 566 | 557 | 572 |
| Return on allocated capital (ROAC) | 3% | 14% | 27% | 8% | 8% | 13% |
| Cost/income ratio, banking | 88% | 66% | 56% | 71% | 71% | 70% |
| Combined ratio, non-life insurance | 82% | 85% | 94% | 84% | 81% | 82% |
| Bulgaria | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2020 | FY 2019 | 4Q 2019 | 3Q 2019 | 2Q 2019 | 1Q 2019 |
| Breakdown P&L | ||||||
| Net interest income | 36 | 141 | 36 | 36 | 35 | 35 |
| Non-life insurance before reinsurance | 18 | 60 | 13 | 15 | 16 | 16 |
| Earned premiums Non-life | 31 | 122 | 31 | 32 | 31 | 29 |
| Technical charges Non-life | -13 | -62 | -18 | -17 | -15 | -12 |
| Life insurance before reinsurance | 4 | 16 | 4 | 3 | 4 | 4 |
| Earned premiums Life | 11 | 36 | 9 | 8 | 9 | 11 |
| Technical charges Life | -7 | -21 | -4 | -5 | -5 | -7 |
| Ceded reinsurance result | -2 | -5 | 0 | -2 | -2 | -2 |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 0 | 15 | 3 | 4 | 4 | 4 |
| Net realised result from debt instr FV through OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Net fee and commission income | 6 | 24 | 5 | 6 | 6 | 6 |
| Net other income | 0 | 1 | 1 | 1 | 0 | 0 |
| TOTAL INCOME | 62 | 252 | 63 | 63 | 63 | 63 |
| Operating expenses | -48 | -139 | -33 | -30 | -29 | -47 |
| Impairment | -3 | -9 | 0 | -6 | -1 | -2 |
| On financial assets at amortised cost and at FV through OCI | -3 | -5 | 4 | -6 | -1 | -2 |
| On other | 0 | -4 | -3 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 11 | 104 | 31 | 26 | 33 | 15 |
| Income tax expense | -1 | -11 | -3 | -3 | -3 | -2 |
| RESULT AFTER TAX | 10 | 93 | 27 | 23 | 29 | 13 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 10 | 93 | 27 | 23 | 29 | 13 |
| Banking | 4 | 76 | 24 | 20 | 24 | 7 |
| Insurance | 6 | 17 | 3 | 3 | 5 | 6 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 3 213 | 3 161 | 3 161 | 3 064 | 2 927 | 2 826 |
| of which Mortgage loans (end of period) | 703 | 693 | 693 | 675 | 659 | 645 |
| Customer deposits and debt certificates excl. repos (end of period) | 4 497 | 4 439 | 4 439 | 4 216 | 4 291 | 4 286 |
| Technical provisions plus unit-linked, life insurance | ||||||
| Interest Guaranteed (end of period) | 92 | 89 | 89 | 91 | 92 | 91 |
| Unit-Linked (end of period) | 41 | 41 | 41 | 37 | 31 | 27 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 3 770 | 3 413 | 3 413 | 3 338 | 3 554 | 3 237 |
| Required capital, insurance (end of period) | 53 | 49 | 49 | 48 | 48 | 47 |
| Allocated capital (end of period) | 450 | 414 | 414 | 405 | 428 | 393 |
| Return on allocated capital (ROAC) | 9% | 23% | 27% | 24% | 30% | 14% |
| Cost/income ratio, banking | 86% | 56% | 51% | 47% | 46% | 81% |
| Combined ratio, non-life insurance | 82% | 88% | 89% | 91% | 89% | 82% |
| Ireland | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2020 | FY 2019 | 4Q 2019 | 3Q 2019 | 2Q 2019 | 1Q 2019 |
| Breakdown P&L | ||||||
| Net interest income | 71 | 263 | 67 | 66 | 65 | 65 |
| Non-life insurance before reinsurance | 0 | 0 | 0 | 0 | 0 | 0 |
| Earned premiums Non-life | 0 | 0 | 0 | 0 | 0 | 0 |
| Technical charges Non-life | 0 | 0 | 0 | 0 | 0 | 0 |
| Life insurance before reinsurance | 0 | 0 | 0 | 0 | 0 | 0 |
| Earned premiums Life | 0 | 0 | 0 | 0 | 0 | 0 |
| Technical charges Life | 0 | 0 | 0 | 0 | 0 | 0 |
| Ceded reinsurance result | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 2 | -4 | 0 | 0 | 0 | -3 |
| Net realised result from debt instr FV through OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Net fee and commission income | -1 | -2 | 0 | 0 | -1 | -1 |
| Net other income | 0 | -23 | -1 | -18 | -4 | 0 |
| TOTAL INCOME | 71 | 235 | 67 | 48 | 61 | 60 |
| Operating expenses | -60 | -229 | -75 | -47 | -51 | -56 |
| Impairment | 2 | 33 | 14 | 7 | 0 | 12 |
| On financial assets at amortised cost and at FV through OCI | 1 | 33 | 14 | 7 | 0 | 12 |
| On other | 0 | 0 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 13 | 39 | 6 | 8 | 10 | 16 |
| Income tax expense | -2 | -10 | -3 | -3 | -1 | -2 |
| RESULT AFTER TAX | 12 | 29 | 2 | 4 | 9 | 14 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 12 | 29 | 2 | 4 | 9 | 14 |
| Banking | 12 | 29 | 2 | 4 | 9 | 14 |
| Insurance | 0 | 0 | 0 | 0 | 0 | 0 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 9 754 | 9 760 | 9 760 | 9 661 | 9 562 | 9 748 |
| of which Mortgage loans (end of period) | 9 651 | 9 654 | 9 654 | 9 531 | 9 435 | 9 348 |
| Customer deposits and debt certificates excl. repos (end of period) | 4 978 | 5 169 | 5 169 | 5 145 | 5 056 | 5 022 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 6 057 | 6 077 | 6 077 | 6 216 | 6 182 | 5 817 |
| Allocated capital (end of period) | 639 | 650 | 650 | 665 | 661 | 622 |
| Return on allocated capital (ROAC) | 7% | 4% | 1% | 3% | 5% | 9% |
| Cost/income ratio, banking | 83% | 97% | 113% | 98% | 84% | 93% |
| Group centre - Breakdown net result | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2020 | FY 2019 | 4Q 2019 | 3Q 2019 | 2Q 2019 | 1Q 2019 |
| Operational costs of the Group activities | -15 | -80 | -34 | -14 | -14 | -18 |
| Capital and treasury management | -11 | -26 | -8 | -9 | -7 | -3 |
| Holding of participations | -3 | 9 | -2 | 1 | 21 | -11 |
| Results companies in rundown | 3 | 24 | 2 | 12 | 5 | 4 |
| Other | -18 | 51 | 9 | 9 | -1 | 34 |
| Total net result for the Group centre | -43 | -23 | -33 | 0 | 4 | 7 |
| Group Centre | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2020 | FY 2019 | 4Q 2019 | 3Q 2019 | 2Q 2019 | 1Q 2019 |
| Breakdown P&L | ||||||
| Net interest income | -16 | -38 | -9 | -8 | -11 | -11 |
| Non-life insurance before reinsurance | 2 | 10 | 4 | 2 | 2 | 3 |
| Earned premiums Non-life | 2 | 10 | 2 | 3 | 3 | 2 |
| Technical charges Non-life | 0 | 0 | 1 | -2 | -1 | 1 |
| Life insurance before reinsurance | 0 | 0 | 0 | 0 | 0 | 0 |
| Earned premiums Life | 0 | 0 | 0 | 0 | 0 | 0 |
| Technical charges Life | 0 | 0 | 0 | 0 | 0 | 0 |
| Ceded reinsurance result | 5 | -9 | 0 | -1 | 2 | -10 |
| Dividend income | 1 | 3 | 1 | 0 | 1 | 1 |
| Net result from financial instruments at fair value through profit or loss | -39 | 41 | 10 | 14 | -21 | 38 |
| Net realised result from debt instr FV through OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Net fee and commission income | -2 | -3 | 0 | 0 | -1 | -2 |
| Net other income | 0 | 3 | -2 | 5 | 2 | -2 |
| TOTAL INCOME | -48 | 6 | 4 | 12 | -27 | 17 |
| Operating expenses | -21 | -116 | -48 | -23 | -21 | -24 |
| Impairment | 9 | 32 | 11 | 10 | 5 | 6 |
| On financial assets at amortised cost and at FV through OCI | 9 | 32 | 11 | 10 | 5 | 6 |
| On other | 0 | 0 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | -60 | -78 | -32 | -1 | -43 | -2 |
| Income tax expense | 18 | 55 | -1 | 1 | 47 | 9 |
| RESULT AFTER TAX | -43 | -23 | -33 | 0 | 4 | 7 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | -43 | -23 | -33 | 0 | 4 | 7 |
| Of which banking | -49 | 1 | -17 | 5 | 0 | 12 |
| Of which holding | 3 | -25 | -26 | -1 | 3 | -1 |
| Of which insurance | 4 | 2 | 10 | -4 | 1 | -4 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 0 | 1 | 1 | 0 | 0 | 0 |
| of which Mortgage loans (end of period) | 0 | 0 | 0 | 0 | 0 | 0 |
| Customer deposits and debt certificates excl. repos (end of period) | 9 426 | 8 999 | 8 999 | 9 806 | 9 089 | 8 332 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 2 339 | 4 554 | 4 554 | 2 266 | 2 607 | 2 652 |
| Risk-weighted assets, insurance (end of period, Basel III fully loaded) | 9 133 | 9 133 | 9 133 | 9 133 | 9 133 | 9 133 |
| Required capital, insurance (end of period) | -22 | -15 | -15 | 2 | 5 | 6 |
| Allocated capital (end of period) | 224 | 473 | 473 | 245 | 284 | 290 |
Gives an idea of the amount of profit over a certain period that is attributable to one share (and, where applicable, including dilutive instruments).
| Calculation (in millions of EUR) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| Result after tax, | 'Consolidated income statement' | |||
| attributable to equity holders of the parent (A) | 5 - |
2 489 | 430 | |
| Coupon on the additional tier-1 instruments | 'Consolidated statement of changes in equity' | |||
| included in equity (B) | - 12 | 56 | 21 | |
| Average number of ordinary shares less treasury shares (in millions) in the period (C) |
Note 5.10 | 416 | 416 | 416 |
| or | ||||
| Average number of ordinary shares plus dilutive options | 416 | 416 | 416 | |
| less treasury shares in the period (D) | ||||
| Basic = (A-B) / (C) (in EUR) | -0.04 | 5.85 | 0.98 | |
| Diluted = (A-B) / (D) (in EUR) | -0.04 | 5.85 | 0.98 |
Gives an insight into the technical profitability (i.e. after eliminating investment returns, among other items) of the non-life insurance business, more particularly the extent to which insurance premiums adequately cover claim payments and expenses. The combined ratio takes ceded reinsurance into account.
| Calculation (in millions of EUR or %) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| Technical insurance charges, including the internal cost of settling claims (A) |
Note 3.7.1 | 275 | 1 006 | 267 |
| Earned insurance premiums (B) | Note 3.7.1 | 436 | 1 693 | 409 |
| + | Note 3.7.1 | |||
| Operating expenses (C) | 145 | 526 | 141 | |
| Written insurance premiums (D) | Note 3.7.1 | 543 | 1 728 | 512 |
| = (A/B)+(C/D) | 89.7% | 89.9% | 92.7% |
A risk-weighted measure of the group's solvency, based on common equity tier-1 capital.
| Calculation (in millions of EUR or %) | 1Q 2020 | ||
|---|---|---|---|
| Detailed calculation 'Danish compromise' table in the 'Solvency KBC Group' section.' | |||
| Fully loaded | 16.3% | 17.1% | 15.7% |
The common equity ratio at the end of 2019 has been restated taking into account the withdrawal of the final gross dividend over 2019 profit of 2.5 euros per share, as communicated by the KBC Board of Directors on 30 March 2020.
Gives an impression of the relative cost efficiency (costs relative to income) of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| Cost/income ratio | ||||
| Operating expenses of the banking activities (A) | 'Consolidated income statement': component of 'Operating expenses' |
1 212 | 3 800 | 1 161 |
| Total income of the banking activities (B) | 'Consolidated income statement': component of "Total income" |
1 326 | 6 563 | 1 617 |
| =(A) / (B) | 91.4% | 57.9% | 71.8% |
Where relevant, we also estimate exceptional and/or non-operating items when calculating the cost/income ratio. The adjustments include: MTM ALM derivatives (fully excluded), bank taxes (including contributions to European Single Resolution Fund) are included pro rata and hence spread over all quarters of the year instead of being recognised for the most part upfront (as required by IFRIC 21) and one-off items. The Cost/Income ratio adjusted for specific items is 69% in 1Q 2020 (versus 57% in 1Q 2019).
Indicates the proportion of impaired loans (see 'Impaired loans ratio' for definition) that are covered by impairment charges. Where appropriate, the numerator and denominator in the formula may be limited to impaired loans that are more than 90 days past due.
| Calculation (in millions of EUR or %) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| Specific impairment on loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
2 568 | 2 584 | 3 223 |
| Outstanding impaired loans (B) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
5 921 | 6 160 | 7 108 |
| = (A) / (B) | 43.4% | 42.0% | 45.3% |
Gives an idea of loan impairment charges recognised in the income statement for a specific period, relative to the total loan portfolio (see 'Loan portfolio' for definition). In the longer term, this ratio can provide an indication of the credit quality of the portfolio.
| Calculation (in millions of EUR or %) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| Net changes in impairment for credit risks (A) |
'Consolidated income statement': component of 'Impairment' |
120 | 204 | દક |
| Average outstanding loan portfolio (B) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
177 566 | 170 128 | 165 440 |
| = (A) (annualised) / (B) | 0.27% | 0.12% | 0.16% |
The credit cost ratio as of 1Q2020 includes a management overlay of 43 million euros related to COVID-19 stress applied on a certain number of (sub)sectors (see detail in note 1.4). Excluding this management overlay, the credit cost ratio amounts to 0.17%.
Indicates the proportion of impaired loans in the loan portfolio (see 'Loan portfolio' for definition) and, therefore, gives an idea of the creditworthiness of the portfolio. Impaired loans are loans where it is unlikely that the full contractual principal and interest will be repaid/paid. These loans have a KBC default status of PD 10, PD 11 or PD 12 and correspond to the definition of 'nonperforming' used by the European Banking Authority.
| Calculation (in millions of EUR or %) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| Amount outstanding of impaired loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
5 921 | 6 160 | 7 108 |
| Total outstanding loan portfolio (B) | 'Credit risk: loan portfolio overview in the 'Credit risk' section |
179 702 | 175 431 | 166 055 |
| = (A) / (B) | 3.3% | 3.5% | 4.3% |
Gives an idea of the group's solvency, based on a simple non-risk-weighted ratio.
| Calculation (in millions of EUR or %) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| Regulatory available tier-1 capital (A) | Leverage ratio KBC Group (Basel III fully loaded table in the 'Leverage KBC Group' section) |
18 229 | 18 489 | 16 612 |
| Total exposure measures (total of non-risk-weighted on and off-balance sheet items, with a number of adjustments) (B) |
Leverage ratio KBC Group (Basel III fully loaded table in the 'Leverage KBC Group' section) |
281 748 | 273 029 | 274 613 |
| = (A) / (B) | 6.5% | 6.8% | 6.0% |
The leverage ratio at the end of 2019 has been restated taking into account the withdrawel of the final gross dividend over 2019 profit of 2.5 euros per share, as communicated by the KBC Board of Directors on 30 March 2020.
Gives an idea of the bank's liquidity position in the short term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-month period.
| Calculation (in millions of EUR or %) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| Stock of high-quality liquid assets (A) | Based on the European Commission's Delegated Act on LCR and the European Banking Authority's guidelines for LCR disclosure |
73 621 | 74 884 | 79 450 |
| Total net cash outflows | 54 541 | 54 415 | 56 850 | |
| over the next 30 calendar days (B) | ||||
| = (A) / (B) | 135% | 138% | 140% | |
From year-end 2017 actuals, KBC discloses 12 months average LCR in accordance to EBA guidelines on LCR disclosure.
Gives an idea of the magnitude of (what are mainly pure, traditional) lending activities.
| Calculation (in millions of EUR or %) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| Loans and advances to customers (A) | Note 4.1, component of 'Loans and advances to customers' |
158 364 | 155 816 | 148 517 |
| + | ||||
| Reverse repos (not with Central Banks) (B) | Note 4.1, component of 'Reverse repos with credit institutions and investment firms |
3 562 | 1 559 | 637 |
| + | ||||
| Debt instruments issued by corporates and by credit institutions and investment firms (banking) (C) |
Note 4.1, component of 'Debt instruments issued by corporates and by credit institutions and investment firms' |
6 180 | 5 894 | 5 603 |
| + | ||||
| Other exposures to credit institutions (D) | 4 869 | 4 629 | 4 954 | |
| + | ||||
| Financial guarantees granted to clients and other commitments (E) |
Note 6.1, component of 'Financial guarantees given' |
8 419 | 8 160 | 8 596 |
| + | ||||
| Impairment on loans (F) | Note 4.2, component of 'Impairment' |
2 862 | 2 866 | 3 539 |
| + | ||||
| Insurance entities (G) | Note 4.1, component of 'Loans and advances to customers' |
- 2 289 | 2 288 | - 2 320 |
| + | ||||
| Non-loan-related receivables (H) | - 1112 | - 738 | 934 | |
| + | ||||
| Other (I) | Component of Note 4.1 | - 1 153 | - 468 | - 2 537 |
| Gross Carrying amount = (A)+(B)+(C)+(D)+(E)+(F)+(G)+(H)+(I) | 179 702 | 175 431 | 166 055 |
Gives an idea of the net interest income of the banking activities (one of the most important sources of revenue for the group) relative to the average total interest-bearing assets of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| Net interest income of the banking activities (A) | 'Consolidated income statement': component of 'Net interest income' |
983 | 3 853 | 942 |
| Average interest-bearing assets of the banking activities (B) 'Consolidated balance sheet': component of Total | assets' | 200 063 | 194 731 | 190 157 |
| = (A) (annualised x360/number of calendar days) / (B) | 1.97% | 1.95% | 1.98% |
From 1Q 2018 the definition of NIM has been updated, it concerns banking group NII excluding dealing room and the net positive impact of ALM FX swaps & repos.
Gives an idea of the bank's structural liquidity position in the long term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-year period.
| Calculation (in millions of EUR or %) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| Available amount of stable funding (A) | Basel III, the net stable funding ratio (Basel Committee on Banking Supervision publication, October 2014) |
176 050 | 174 977 | 170 100 |
| Required amount of stable funding (B) | 131 156 | 128 845 | 123 050 | |
| = (A) / (B) | 134.2% | 135.8% | 138.2% |
Gives the carrying value of a KBC share, i.e. the value in euros represented by each share in the parent shareholders' equity of KBC.
| Calculation (in millions of EUR or %) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| Parent shareholders' equity (A) | 'Consolidated balance sheet' | 18 220 | 18 865 | 17 924 |
| Number of ordinary shares less treasury shares | Note 5.10 | 416 | 416 | 416 |
| (at period-end) (B) | ||||
| = (A) / (B) (in EUR) | 43.76 | 45.31 | 43.08 |
Gives an idea of the relative profitability of a business unit, more specifically the ratio of the net result to the capital allocated to the business unit.
| Calculation (in millions of EUR or %) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| BELGIUM BUSINESS UNIT | ||||
| Result after tax (including minority interests) | Note 2.2: Results by segment | - 86 | 1 344 | 176 |
| of the business unit (A) | ||||
| The average amount of capital allocated to the business unit | 6 860 | 6 764 | 6 681 | |
| is based on the risk-weighted assets for the banking activities | ||||
| (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
||||
| = (A) annualised / (B) | -5.0% | 19.9% | 10.5% | |
| CZECH REPUBLIC BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business | Note 2.2: Results by segment | 88 | 789 | 177 |
| unit (A) | ||||
| 1 | ||||
| The average amount of capital allocated to the business unit | 1 725 | 1 692 | 1 660 | |
| is based on the risk-weighted assets for the banking activities | ||||
| (under Basel III) and risk-weighted asset equivalents for the | ||||
| insurance activities (under Solvency II) (B) | ||||
| = (A) annualised / (B) | 19.9% | 46.7% | 42.5% | |
| INTERNATIONAL MARKETS BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business Note 2.2: Results by segment | 35 | 379 | 70 | |
| unit (A) | ||||
| 1 | ||||
| The average amount of capital allocated to the business unit | 2 360 | 2 354 | 2 333 | |
| is based on the risk-weighted assets for the banking activities | ||||
| (under Basel III) and risk-weighted asset equivalents for the | ||||
| insurance activities (under Solvency II) (B) | ||||
| = (A) annualised / (B) | 5.9% | 16.1% | 12.1% |
Gives an idea of the relative profitability of the group, more specifically the ratio of the net result to equity.
| Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|
| 'Consolidated income statement' | 5 | 2 489 | 430 |
| Coupon on the additional tier-1 instruments included in equity 'Consolidated statement of changes in equity' | 12 | 56 | 21 |
| 'Consolidated statement of changes in equity' | 17 375 | 16 978 | 16 651 |
| -0.4% | 14.3% | 9.8% | |
The return on equity amounts to 4% when including evenly spreading of the bank taxes throughout the year.
Gives the indication of the sales activities of life insurance products including unit-linked.
| Calculation (in millions of EUR or %) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| Life Insurance - earned premiums (before reinsurance) (A) 'Consolidated income statement' | 297 | 1 323 | 351 | |
| + | ||||
| Life insurance: difference between written and earned premiums (before reinsurance) (B) + |
1 | |||
| Investment contracts without discretionary participation feature (large part of unit-linked) - margin deposit accounting (C) |
128 | 525 | 164 | |
| Total sales Life (A)+ (B) + (C) | 427 | 1 849 | 516 |
Measures the solvency of the insurance business, calculated under Solvency II.
| Calculation | 1Q 2020 | 2019 | |
|---|---|---|---|
| Detailed calculation under 'Solvence consolidated 'table in the Solvency banking and insurance activities separately section |
212% | 202% | 210% |
Total assets under management (AuM) comprise third-party assets and KBC group assets managed by the group's various asset management companies (KBC Asset Management, ČSOB Asset Management, etc.), as well as assets under advisory management at KBC Bank. The assets, therefore, consist mainly of KBC investment funds and unit-linked insurance products, assets under discretionary and advisory management mandates of (mainly retail, private banking and institutional) clients, and certain group assets. The size and development of total AuM are major factors behind net fee and commission income (generating entry and management fees) and hence account for a large part of any change in this income line. In that respect, the AuM of a fund that is not sold directly to clients but is instead invested in by another fund or via a discretionary/advisory management portfolio, are also included in the total AuM figure, in view of the related work and any fee income linked to them.
| Calculation (in billions of EUR or quantity) | Reference | 1Q 2020 | 2019 | 1Q 2019 |
|---|---|---|---|---|
| Belgium Business Unit (A) | Company presentation on www.kbc.com | 178 | 200 | 195 |
| + | ||||
| Czech Republic Business Unit (B) | 10 | 11 | 10 | |
| + | ||||
| International Markets Business Unit (C) | 5 | 5 | 5 | |
| A)+(B)+(C) | 193 | 216 | 210 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.